MARK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
Log-Odds: S Sites / S Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| O00231 | S298 | Sugiyama | PSMD11 | RYAGRQTEALKCVAQASKNRsLADFEKALTDYRAELRDDPI |
| O00468 | S641 | Sugiyama | AGRN AGRIN | PRCEHPPPGPVCGSDGVTyGsACELREAACLQQtQIEEARA |
| O14639 | S452 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | PtPsAEGyQDVRDRMIHRstsQGsINsPVySRHsYtPTTSR |
| O14910 | S135 | Sugiyama | LIN7A MALS1 VELI1 | DEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLKRGDQL |
| O14974 | S445 | Sugiyama | PPP1R12A MBS MYPT1 | EEERKDEsPATWRLGLRKtGsyGALAEItASKEGQKEKDTA |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O15355 | S349 | Sugiyama | PPM1G PPM1C | tTAVVALIRGKQLIVANAGDsRCVVsEAGKALDMsyDHKPE |
| O15460 | S531 | Sugiyama | P4HA2 UNQ290/PRO330 | KWVSNKWFHERGQEFLRPCGstEVD________________ |
| O43290 | S378 | Sugiyama | SART1 | DGLRERELEEIRAKLRLQAQsLSTVGPRLASEYLtPEEMVT |
| O43707 | S763 | Sugiyama | ACTN4 | IARTINEVENQILtRDAKGIsQEQMQEFRASFNHFDKDHGG |
| O43765 | S197 | Sugiyama | SGTA SGT SGT1 | EAVAYYKKALELDPDNEtyKsNLKIAELKLREAPSPTGGVG |
| O43815 | S227 | Sugiyama | STRN | NGTEAEVKETAMIAKSELtDsAsVLDNFKFLEsAAADFsDE |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O43852 | S69 | Sugiyama | CALU | HDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKDGFVt |
| O60333 | S1057 | Sugiyama | KIF1B KIAA0591 KIAA1448 | DNEYFNQSDFSSVAMTRsGLsLEELRIVEGQGQSSEVItPP |
| O60716 | S230 | Sugiyama | CTNND1 KIAA0384 | PDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGyRA |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O60749 | S119 | Sugiyama | SNX2 TRG9 | AVtPVtPttLIAPRIESKsMsAPVIFDRsREEIEEEANGDI |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O75122 | S313 | Sugiyama | CLASP2 KIAA0627 | YNSLEPSYQKSLQTYLKssGsVAsLPQsDRsssssQEsLNR |
| O75122 | S327 | Sugiyama | CLASP2 KIAA0627 | YLKssGsVAsLPQsDRsssssQEsLNRPFSSKWSTANPSTV |
| O75140 | S496 | Sugiyama | DEPDC5 KIAA0645 | QCLTTCRSVRERESHSRKsAssCDVsssPsLPSRTLPTEEV |
| O75179 | S243 | Sugiyama | ANKRD17 GTAR KIAA0697 | RAEStANAGQSDNRSLAEACsEGDVNAVRKLLIEGRSVNEH |
| O75347 | S60 | Sugiyama | TBCA | MRAEDGENyDIKKQAEILQEsRMMIPDCQRRLEAAyLDLQR |
| O75390 | S453 | Sugiyama | CS | LAQLIWSRALGFPLERPKSMsTEGLMKFVDSKSG_______ |
| O94776 | S54 | Sugiyama | MTA2 MTA1L1 PID | ANGNVEAKVVCLFRRRDIsssLNSLADSNAREFEEESKQPG |
| O94874 | S777 | Sugiyama | UFL1 KIAA0776 MAXER NLBP RCAD | LDKEQEDVASTTRKELQELSssIKDLVLKSRKSsVTEE___ |
| O94874 | S778 | Sugiyama | UFL1 KIAA0776 MAXER NLBP RCAD | DKEQEDVASTTRKELQELSssIKDLVLKSRKSsVTEE____ |
| O95155 | S105 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | LsssPsNsLEtQsQsLsRsQsMDIDGVSCEKsMsQVDVDsG |
| O95155 | S79 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | NMtPAtsPIGASGVAHRsQssEGVssLsssPsNsLEtQsQs |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95671 | T234 | Sugiyama | ASMTL | PPRPEDLRRsVKHDsIPAADtFEDLsDVEGGGsEPTQRDAG |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| O95816 | S31 | Sugiyama | BAG2 | NEGRFCRsssMADRsSRLLEsLDQLELRVEALREAATAVEQ |
| O95819 | S800 | Sugiyama | MAP4K4 HGK KIAA0687 NIK | DVEQEGADESTSGPEDTRAAsSLNLSNGETESVKTMIVHDD |
| P00338 | S105 | Sugiyama | LDHA PIG19 | VTANsKLVIItAGARQQEGEsRLNLVQRNVNIFKFIIPNVV |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S319 | Sugiyama | LDHA PIG19 | GISDLVKVTLtsEEEARLKKsADtLWGIQKELQF_______ |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P00558 | S174 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | LSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKEL |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00568 | S38 | Sugiyama | AK1 | GSGKGTQCEKIVQKyGytHLstGDLLRSEVSSGSARGKKLs |
| P02545 | S295 | Sugiyama | LMNA LMN1 | RQsAERNsNLVGAAHEELQQsRIRIDsLsAQLsQLQKQLAA |
| P04040 | S515 | Sugiyama | CAT | ALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL________ |
| P04040 | S517 | Sugiyama | CAT | LDKYNAEKPKNAIHtFVQsGsHLAAREKANL__________ |
| P04040 | T511 | Sugiyama | CAT | SHIQALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL____ |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P04083 | S201 | Sugiyama | ANXA1 ANX1 LPC1 | LsLAKGDRsEDFGVNEDLADsDARALyEAGERRKGtDVNVF |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S176 | Sugiyama | HSPB1 HSP27 HSP28 | sLsPEGtLTVEAPMPKLAtQsNEItIPVtFEsRAQLGGPEA |
| P04792 | S187 | Sugiyama | HSPB1 HSP27 HSP28 | APMPKLAtQsNEItIPVtFEsRAQLGGPEAAKsDETAAK__ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | T184 | Sugiyama | HSPB1 HSP27 HSP28 | TVEAPMPKLAtQsNEItIPVtFEsRAQLGGPEAAKsDETAA |
| P05023 | S369 | Sugiyama | ATP1A1 | KRMARKNCLVKNLEAVETLGstsTICSDKTGTLTQNRMTVA |
| P05198 | S219 | Sugiyama | EIF2S1 EIF2A | CYGYEGIDAVKEALRAGLNCsTENMPIKINLIAPPRYVMTT |
| P05198 | S52 | PSP | EIF2S1 EIF2A | AYVSLLEYNNIEGMILLsELsRRRIRSINKLIRIGRNECVV |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P05783 | S401 | Sugiyama | KRT18 CYK18 PIG46 | RRLLEDGEDFNLGDALDssNsMQtIQKtTTRRIVDGKVVsE |
| P05787 | S280 | Sugiyama | KRT8 CYK8 | IAEVKAQyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDL |
| P05787 | S477 | Sugiyama | KRT8 CYK8 | SSRAVVVKKIETRDGKLVsEssDVLPK______________ |
| P06280 | S176 | Sugiyama | GLA | AQTFADWGVDLLKFDGCYCDsLENLADGYKHMSLALNRTGR |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | S349 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | AKAVNEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMV |
| P06733 | S353 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMVsHRs |
| P07195 | S106 | Sugiyama | LDHB | VtANSKIVVVtAGVRQQEGEsRLNLVQRNVNVFKFIIPQIV |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | S320 | Sugiyama | LDHB | GLtsVINQKLKDDEVAQLKKsADtLWDIQKDLKDL______ |
| P07195 | S44 | Sugiyama | LDHB | ITVVGVGQVGMACAISILGKsLADELALVDVLEDKLKGEMM |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07339 | S42 | Sugiyama | CTSD CPSD | VRIPLHKFTSIRRtMsEVGGsVEDLIAKGPVSKYSQAVPAV |
| P07384 | S474 | Sugiyama | CAPN1 CANPL1 PIG30 | GQPAVHLKRDFFLANAsRARsEQFINLREVSTRFRLPPGEY |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07437 | S40 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | FWEVISDEHGIDPTGtyHGDsDLQLDRIsVyyNEAtGGKyV |
| P07711 | S329 | Sugiyama | CTSL CTSL1 | GGyVKMAKDRRNHCGIAsAAsyPtV________________ |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07814 | S747 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | ETSAPFKERPtPsLNNNCttsEDsLVLyNRVAVQGDVVREL |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S164 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | VAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGT |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S399 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNLVKK |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P08195 | S286 | Sugiyama | SLC3A2 MDU1 | KNQKDDVAQtDLLQIDPNFGsKEDFDsLLQsAKKKSIRVIL |
| P08195 | S402 | Sugiyama | SLC3A2 MDU1 | SSDLQQILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQY |
| P08195 | S518 | Sugiyama | SLC3A2 MDU1 | DIPGAVSANMTVKGQsEDPGsLLsLFRRLsDQRsKERSLLH |
| P08238 | S159 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | VAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGT |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08238 | S391 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNIVKK |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | S490 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRKRGFEV |
| P08670 | S438 | Sugiyama | VIM | FssLNLREtNLDsLPLVDtHsKRTLLIKtVEtRDGQVINEt |
| P09211 | S66 | Sugiyama | GSTP1 FAEES3 GST3 | ASCLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGKDQQE |
| P09923 | S189 | Sugiyama | ALPI | RVQHAsPAGtyAHtVNRNWysDADMPASARQEGCQDIATQL |
| P09960 | S240 | Sugiyama | LTA4H LTA4 | LVWSEKEQVEKSAyEFsETEsMLKIAEDLGGPYVWGQYDLL |
| P0CG41 | S140 | Sugiyama | CTAGE8 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| P0CG47 | S57 | Sugiyama | UBB | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0CG48 | S57 | Sugiyama | UBC | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P10398 | S157 | Sugiyama | ARAF ARAF1 PKS PKS2 | SSKVPTVCVDMSTNRQQFyHsVQDLsGGsRQHEAPsNRPLN |
| P10636 | S355 | SIGNOR | MAPT MAPTL MTBT1 TAU | PEARGPsLGEDTKEADLPEPsEKQPAAAPRGKPVsRVPQLK |
| P10809 | S410 | Sugiyama | HSPD1 HSP60 | LNERLAKLsDGVAVLKVGGtsDVEVNEKKDRVtDALNAtRA |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11279 | S141 | Sugiyama | LAMP1 | NLSDTHLFPNASSKEIKtVEsITDIRADIDKKYRCVSGTQV |
| P11413 | S117 | Sugiyama | G6PD | KLEDFFARNsyVAGQyDDAAsyQRLNsHMNALHLGsQANRL |
| P11586 | S318 | Sugiyama | MTHFD1 MTHFC MTHFD | FKPGKWMIQYNNLNLKTPVPsDIDIsRSCKPKPIGKLAREI |
| P11586 | S765 | Sugiyama | MTHFD1 MTHFC MTHFD | ARMFGIPVVVAVNAFKTDTEsELDLIsRLSREHGAFDAVKC |
| P12004 | S172 | Sugiyama | PCNA | sHIGDAVVIsCAKDGVKFSAsGELGNGNIKLSQTSNVDKEE |
| P12268 | S416 | Sugiyama | IMPDH2 IMPD2 | APGEYFFSDGIRLKKyRGMGsLDAMDKHLssQNRyFsEADK |
| P12814 | S744 | Sugiyama | ACTN1 | IARTINEVENQILtRDAKGIsQEQMNEFRAsFNHFDRDHsG |
| P13473 | S155 | Sugiyama | LAMP2 | LTVDELLAIRIPLNDLFRCNsLSTLEKNDVVQHYWDVLVQA |
| P13489 | S178 | Sugiyama | RNH1 PRI RNH | SCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKDSP |
| P13637 | S359 | Sugiyama | ATP1A3 | KRMARKNCLVKNLEAVETLGstsTICSDKTGTLTQNRMTVA |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13667 | S470 | Sugiyama | PDIA4 ERP70 ERP72 | FAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAMEP |
| P13797 | S540 | Sugiyama | PLS3 | NDDIIVNWVNRTLSEAGKSTsIQSFKDKTISSSLAVVDLID |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14618 | S100 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | tHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTKGPEIR |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S172 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSELI |
| P14625 | S447 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | PKyLNFVKGVVDsDDLPLNVsREtLQQHKLLKVIRKKLVRK |
| P14625 | S551 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKEKQDKIyFMAGsSRKEAEssPFVERLLKKGyEVIyLTEP |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P15311 | S144 | Sugiyama | EZR VIL2 | LLGSYAVQAKFGDYNKEVHKsGyLSsERLIPQRVMDQHKLT |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17987 | S374 | Sugiyama | TCP1 CCT1 CCTA | ERICDDELILIKNTKARTsAsIILRGANDFMCDEMERSLHD |
| P17987 | S544 | Sugiyama | TCP1 CCT1 CCTA | ILRIDDLIKLHPESKDDKHGsyEDAVHsGALND________ |
| P18615 | S115 | Sugiyama | NELFE RD RDBP | KLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLyEs |
| P18615 | S139 | Sugiyama | NELFE RD RDBP | DLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEGPGAG |
| P18669 | S14 | Sugiyama | PGAM1 PGAMA CDABP0006 | _______MAAYKLVLIRHGEsAWNLENRFsGWyDADLsPAG |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18754 | S85 | Sugiyama | RCC1 CHC1 | IPEDVVQAEAGGMHTVCLSKsGQVysFGCNDEGALGRDtsV |
| P18850 | S98 | Sugiyama | ATF6 | NQICTVKDIKAEPQPLsPAssSYsVssPRSVDSYSSTQHVP |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S356 | Sugiyama | NCL | LAVVDVRIGMTRKFGyVDFEsAEDLEKALELtGLKVFGNEI |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | Y463 | Sugiyama | NCL | EKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsG |
| P20674 | S104 | Sugiyama | COX5A | PEPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYP |
| P21108 | S11 | Sugiyama | PRPS1L1 PRPS3 PRPSL | __________MPNIKIFsGssHQDLSQKIADRLGLELGKVV |
| P21333 | S2152 | Sugiyama | FLNA FLN FLN1 | VKVTGEGRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQ |
| P21333 | S2158 | Sugiyama | FLNA FLN FLN1 | GRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQDMtAQV |
| P22059 | S379 | Sugiyama | OSBP OSBP1 | FFDAPEIITMPENLGHKRtGsNIsGAssDIsLDEQyKHQLE |
| P22059 | S386 | Sugiyama | OSBP OSBP1 | ITMPENLGHKRtGsNIsGAssDIsLDEQyKHQLEETKKEKR |
| P22314 | S46 | Sugiyama | UBA1 A1S9T UBE1 | AQsVLsEVPSVPTNGMAKNGsEADIDEGLysRQLyVLGHEA |
| P22466 | S116 | Sugiyama | GAL GAL1 GALN GLNN | FLHLKEAGALDRLLDLPAAAssEDIERs_____________ |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | S324 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNYNQQPSNYGPMKsGNFGGsRNMGGPyGGGNyGPGGsGGs |
| P23284 | S150 | Sugiyama | PPIB CYPB | LKHyGPGWVsMANAGKDTNGsQFFITTVKTAWLDGKHVVFG |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P24534 | S174 | Sugiyama | EEF1B2 EEF1B EF1B | DMAKLEECVRsIQADGLVWGssKLVPVGyGIKKLQIQCVVE |
| P24539 | S142 | Sugiyama | ATP5PB ATP5F1 | DFADKLNEQKLAQLEEAKQAsIQHIQNAIDTEKsQQALVQK |
| P24844 | S20 | PSP | MYL9 MLC2 MRLC1 MYRL2 | _MssKRAKAKtTKKRPQRAtsNVFAMFDQSQIQEFKEAFNM |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P25705 | S198 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | GIIPRIsVREPMQTGIKAVDsLVPIGRGQRELIIGDRQTGK |
| P25815 | S24 | Sugiyama | S100P S100E | LETAMGMIIDVFSRYSGSEGstQtLTKGELKVLMEKELPGF |
| P26038 | S144 | Sugiyama | MSN | LLASyAVQSKYGDFNKEVHKsGYLAGDKLLPQRVLEQHKLN |
| P26232 | S667 | Sugiyama | CTNNA2 CAPR | YDVRsRtsVQtEDDQLIAGQsARAIMAQLPQEEKAKIAEQV |
| P26373 | S106 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | IHKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLIL |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27816 | S1073 | ELM | MAP4 | DVKIEsQKLNFKEKAQAKVGsLDNVGHLPAGGAVKTEGGGS |
| P27816 | S941 | ELM | MAP4 | SRLAtNtsAPDLKNVRsKVGstENIKHQPGGGRAKVEKKTE |
| P28066 | S180 | Sugiyama | PSMA5 | GtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSLI |
| P28838 | S180 | Sugiyama | LAP3 LAPEP PEPS | YEYDDLKQKKKMAVSAKLyGsGDQEAWQKGVLFAsGQNLAR |
| P29144 | S176 | Sugiyama | TPP2 | FDVANNGSsQANKLIKEELQsQVELLNsFEKKYSDPGPVYD |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P30048 | S199 | Sugiyama | PRDX3 AOP1 | SGLALRGLFIIDPNGVIKHLsVNDLPVGRSVEETLRLVKAF |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30086 | S54 | Sugiyama | PEBP1 PBP PEBP | VDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAP |
| P30533 | S230 | Sugiyama | LRPAP1 A2MRAP | SDIKGSVLHSRHTELKEKLRsINQGLDRLRRVsHQGystEA |
| P30622 | S195 | Sugiyama | CLIP1 CYLN1 RSN | AAKEPsAtPPISNLTKtAsEsIsNLsEAGsIKKGERELKIG |
| P30622 | S197 | Sugiyama | CLIP1 CYLN1 RSN | KEPsAtPPISNLTKtAsEsIsNLsEAGsIKKGERELKIGDR |
| P31150 | S316 | Sugiyama | GDI1 GDIL OPHN2 RABGDIA XAP4 | QVIRIICILSHPIKNtNDANsCQIIIPQNQVNRKSDIYVCM |
| P31327 | S205 | Sugiyama | CPS1 | FEGQPVDFVDPNKQNLIAEVstKDVKVYGKGNPTKVVAVDC |
| P31327 | S537 | Sugiyama | CPS1 | GVELFKRGVLKEYGVKVLGtsVEsIMATEDRQLFSDKLNEI |
| P31327 | S835 | Sugiyama | CPS1 | MCHPsIEGFTPRLPMNKEWPsNLDLRKELSEPSsTRIyAIA |
| P31327 | T536 | Sugiyama | CPS1 | CGVELFKRGVLKEYGVKVLGtsVEsIMATEDRQLFSDKLNE |
| P34897 | S81 | Sugiyama | SHMT2 | QREKDRQCRGLELIAsENFCsRAALEALGsCLNNKYSEGYP |
| P34897 | S90 | Sugiyama | SHMT2 | GLELIAsENFCsRAALEALGsCLNNKYSEGYPGKRyyGGAE |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34932 | S363 | Sugiyama | HSPA4 APG2 HSPH2 | GATRIPAVKEKISKFFGKELsttLNADEAVTRGCALQCAIL |
| P35221 | S668 | Sugiyama | CTNNA1 | FDVRsRtsVQtEDDQLIAGQsARAIMAQLPQEQKAKIAEQV |
| P35241 | S532 | Sugiyama | RDX | EERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHA |
| P35241 | S533 | Sugiyama | RDX | ERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHAE |
| P35250 | S85 | Sugiyama | RFC2 | REGNVPNIIIAGPPGTGKTTsILCLARALLGPALKDAMLEL |
| P35579 | S1943 | Sugiyama | MYH9 | RGDLPFVVPRRMARKGAGDGsDEEVDGKADGAEAKPAE___ |
| P35606 | S350 | Sugiyama | COPB2 | MGDAEIKDGERLPLAVKDMGsCEIyPQtIQHNPNGRFVVVC |
| P36578 | S365 | Sugiyama | RPL4 RPL1 | RNHKLRVDKAAAAAAALQAKsDEKAAVAGKKPVVGKKGKKA |
| P37108 | S25 | Sugiyama | SRP14 | EsEQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGt |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P38646 | S549 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | IVHVSAKDKGTGREQQIVIQssGGLsKDDIENMVKNAEKYA |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39748 | S255 | Sugiyama | FEN1 RAD2 | CESIRGIGPKRAVDLIQKHKsIEEIVRRLDPNKYPVPENWL |
| P40818 | S718 | Sugiyama | USP8 KIAA0055 UBPY | AKPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtP |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46013 | S1098 | Sugiyama | MKI67 | PAARVTGMKKWPRtPKEEAQsLEDLAGFKELFQtPGPsEEs |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46779 | S115 | Sugiyama | RPL28 | HMIRKNKYRPDLRMAAIRRAsAILRSQKPVMVKRKRTRPTK |
| P46939 | S1258 | SIGNOR|EPSD|PSP | UTRN DMDL DRP1 | LLHYLDLETTWLNTLEERMKsTEVLPEKTDAVNEALESLES |
| P46940 | S1448 | Sugiyama | IQGAP1 KIAA0051 | AIRDAKTPDKMKKsKsVKEDsNLtLQEKKEKIQTGLKKLTE |
| P46940 | S482 | Sugiyama | IQGAP1 KIAA0051 | LINRALESGDVNTVWKQLsssVtGLTNIEEENCQRYLDELM |
| P46940 | T484 | Sugiyama | IQGAP1 KIAA0051 | NRALESGDVNTVWKQLsssVtGLTNIEEENCQRYLDELMKL |
| P47712 | S729 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | KEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKPKA |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49321 | S662 | Sugiyama | NASP | LKELLPEIREKIEDAKEsQRsGNVAELALKATLVEsstsGF |
| P49327 | S265 | Sugiyama | FASN FAS | TILNAGTNTDGFKEQGVtFPsGDIQEQLIRSLyQsAGVAPE |
| P49368 | S458 | Sugiyama | CCT3 CCTG TRIC5 | RAVAQALEVIPRTLIQNCGAstIRLLtSLRAKHtQENCEtW |
| P49588 | S627 | Sugiyama | AARS1 AARS | ATHILNFALRSVLGEADQKGsLVAPDRLRFDFTAKGAMSTQ |
| P49588 | S775 | Sugiyama | AARS1 AARS | VTGAEAQKALRKAESLKKCLsVMEAKVKAQTAPNKDVQREI |
| P49736 | S170 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | KRRQVERAtEDGEEDEEMIEsIENLEDLKGHSVREWVsMAG |
| P49790 | S607 | Sugiyama | NUP153 | KtPPEDCEGPFRPAEILKEGsVLDILKsPGFAsPKIDSVAA |
| P50395 | S316 | Sugiyama | GDI2 RABGDIB | QVIRVICILSHPIKNtNDANsCQIIIPQNQVNRKSDIyVCM |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P50395 | T425 | Sugiyama | GDI2 RABGDIB | DAttHFEttCDDIKNIYKRMtGsEFDFEEMKRKKNDIYGED |
| P50542 | S167 | Sugiyama | PEX5 PXR1 | EVTDPLSVSPARWAEEyLEQsEEKLWLGEPEGTATDRWYDE |
| P50990 | S373 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | SEVGDTQVVVFKHEKEDGAIstIVLRGstDNLMDDIERAVD |
| P50990 | S380 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | VVVFKHEKEDGAIstIVLRGstDNLMDDIERAVDDGVNtFK |
| P50990 | T381 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | VVFKHEKEDGAIstIVLRGstDNLMDDIERAVDDGVNtFKV |
| P50993 | S367 | Sugiyama | ATP1A2 KIAA0778 | KRMARKNCLVKNLEAVETLGstsTICSDKTGTLTQNRMTVA |
| P51946 | S15 | Sugiyama | CCNH | ______MYHNsSQKRHWtFSsEEQLARLRADANRKFRCKAV |
| P51991 | S375 | Sugiyama | HNRNPA3 HNRPA3 | ssGsPyGGGyGsGGGsGGyGsRRF_________________ |
| P52272 | S365 | Sugiyama | HNRNPM HNRPM NAGR1 | KMGGMEGPFGGGMENMGRFGsGMNMGRINEILsNALKRGEI |
| P52272 | S528 | Sugiyama | HNRNPM HNRPM NAGR1 | IERMGsGVERMGPAIERMGLsMERMVPAGMGAGLERMGPVM |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52597 | S161 | Sugiyama | HNRNPF HNRPF | ITLPVDPEGKITGEAFVQFAsQELAEKALGKHKERIGHRYI |
| P52597 | S186 | Sugiyama | HNRNPF HNRPF | EKALGKHKERIGHRYIEVFKssQEEVRsysDPPLKFMsVQR |
| P52597 | S187 | Sugiyama | HNRNPF HNRPF | KALGKHKERIGHRYIEVFKssQEEVRsysDPPLKFMsVQRP |
| P52597 | S63 | Sugiyama | HNRNPF HNRPF | VHFIYTREGRQsGEAFVELGsEDDVKMALKKDRESMGHRyI |
| P52788 | S57 | Sugiyama | SMS | ESVHTWQDHGYLATYTNKNGsFANLRIYPHGLVLLDLQSYD |
| P53621 | S389 | Sugiyama | COPA | SYNPAENAVLLCTRAsNLENstyDLytIPKDADsQNPDAPE |
| P53621 | Y391 | Sugiyama | COPA | NPAENAVLLCTRAsNLENstyDLytIPKDADsQNPDAPEGK |
| P53999 | S17 | Sugiyama | SUB1 PC4 RPO2TC1 | ____MPKSKELVsssssGsDsDsEVDKKLKRKKQVAPEKPV |
| P54105 | S42 | Sugiyama | CLNS1A CLCI ICLN | DTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGFSLEYPTIS |
| P54252 | S260 | Sugiyama | ATXN3 ATX3 MJD MJD1 SCA3 | IDMEDEEADLRRAIQLsMQGssRNIsQDMtQtsGTNLTSEE |
| P54577 | S366 | Sugiyama | YARS1 YARS | KQKPMAKGPAKNsEPEEVIPsRLDIRVGKIITVEKHPDADs |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55036 | S266 | Sugiyama | PSMD4 MCB1 | AGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEEEQ |
| P55060 | S931 | Sugiyama | CSE1L CAS XPO2 | KKEHDPVGQMVNNPKIHLAQsLHKLSTACPGRVPSMVSTSL |
| P55769 | S122 | Sugiyama | SNU13 NHP2L1 | CSVTIKEGSQLKQQIQsIQQsIERLLV______________ |
| P55854 | S27 | Sugiyama | SUMO3 SMT3A SMT3H1 | KEGVKTENDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P55957 | S78 | Sugiyama | BID | QtDGNRssHsRLGRIEADsEsQEDIIRNIARHLAQVGDsMD |
| P56524 | S246 | EPSD|PSP | HDAC4 KIAA0288 | NHPVLGMYDAKDDFPLRKTAsEPNLKLRSRLKQKVAERRss |
| P56524 | S467 | PSP | HDAC4 KIAA0288 | DRVSPSIHKLRQHRPLGRtQsAPLPQNAQALQHLVIQQQHQ |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60891 | S11 | Sugiyama | PRPS1 | __________MPNIKIFsGssHQDLSQKIADRLGLELGKVV |
| P60900 | S175 | Sugiyama | PSMA6 PROS27 | DPAGyyCGFKATAAGVKQtEstsFLEKKVKKKFDWTFEQTV |
| P61081 | S175 | Sugiyama | UBE2M UBC12 | NNRRLFEQNVQRSMRGGyIGstyFERCLK____________ |
| P61163 | T248 | Sugiyama | ACTR1A CTRN1 | PQKDETLETEKAQyyLPDGstIEIGPSRFRAPELLFRPDLI |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61326 | S106 | Sugiyama | MAGOH MAGOHA | QELEIVIGDEHISFTTSKIGsLIDVNQSKDPEGLRVFYYLV |
| P61956 | S28 | Sugiyama | SUMO2 SMT3B SMT3H2 | EGVKtENNDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | T70 | Sugiyama | HNRNPK HNRPK | QSKNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsI |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S156 | Sugiyama | YWHAE | AtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLGLALN |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62979 | S57 | Sugiyama | RPS27A UBA80 UBCEP1 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGA |
| P62987 | S57 | Sugiyama | UBA52 UBCEP2 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGI |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63220 | S65 | Sugiyama | RPS21 | RFNGQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF__ |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P78352 | S561 | EPSD|PSP | DLG4 PSD95 | GPTKDRANDDLLSEFPDKFGsCVPHTTRPKREYEIDGRDYH |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S13 | Sugiyama | RPL19 | ________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEIA |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| Q00587 | S350 | Sugiyama | CDC42EP1 BORG5 CEP1 MSE55 | HyPEMDARQERVEVLPQARAsWEsLDEEWRAPQAGsRtPVP |
| Q00610 | S1462 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | VKQLPLVKPYLRSVQNHNNKsVNEsLNNLFITEEDyQALRT |
| Q00610 | S1466 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | PLVKPYLRSVQNHNNKsVNEsLNNLFITEEDyQALRTsIDA |
| Q00613 | S375 | Sugiyama | HSF1 HSTF1 | TDtEGRPPsPPPtstPEKCLsVACLDKNELSDHLDAMDSNL |
| Q00688 | S100 | Sugiyama | FKBP3 FKBP25 | KVSEQVKNVKLNEDKPKEtKsEEtLDEGPPKYTKSVLKKGD |
| Q00688 | S34 | Sugiyama | FKBP3 FKBP25 | QLRSEQLPKKDIIKFLQEHGsDsFLAEHKLLGNIKNVAKTA |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01082 | S2048 | Sugiyama | SPTBN1 SPTB2 | VAEAWLLGQEPyLssREIGQsVDEVEKLIKRHEAFEKSAAT |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01581 | S404 | Sugiyama | HMGCS1 HMGCS | YSLKVTQDATPGSALDKITAsLCDLKSRLDSRTGVAPDVFA |
| Q01650 | S31 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | LAAPAAEEKEEAREKMLAAKsADGsAPAGEGEGVtLQRNIT |
| Q01970 | S1041 | Sugiyama | PLCB3 | TKEGEDEAKRYQEFQNRQVQsLLELREAQVDAEAQRRLEHL |
| Q02818 | S224 | Sugiyama | NUCB1 NUC | RKLEEQQRRHREHPKVNVPGsQAQLKEVWEELDGLDPNRFN |
| Q02878 | S255 | Sugiyama | RPL6 TXREB1 | tEKEKYEITEQRKIDQKAVDsQILPKIKAIPQLQGYLRSVF |
| Q04637 | S1238 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | RDAVKREAALPPVsPLKAALsEEELEKKsKAIIEEyLHLND |
| Q04721 | S1621 | Sugiyama | NOTCH2 | KKQRMTRRSLPGEQEQEVAGsKVFLEIDNRQCVQDSDHCFK |
| Q04726 | S622 | Sugiyama | TLE3 KIAA1547 | VWDLHNQTLVRQFQGHTDGAsCIDISHDGTKLWTGGLDNTV |
| Q05397 | Y397 | PSP | PTK2 FAK FAK1 | ANSEKQGMRtHAVsVsEtDDyAEIIDEEDtytMPSTRDYEI |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q07021 | S164 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | DGEEEPSQGQKVEEQEPELtstPNFVVEVIKNDDGKKALVL |
| Q07021 | S213 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | VGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDSLDW |
| Q07021 | T165 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | GEEEPSQGQKVEEQEPELtstPNFVVEVIKNDDGKKALVLD |
| Q07065 | S433 | Sugiyama | CKAP4 | LQHVEDGVLSMQVASARQTEsLESLLSKSQEHEQRLAALQG |
| Q08AD1 | S464 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | FDKEDSVQRstPNRGITRsIsNEGLtLNNsHVsKHIRKNLS |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q10471 | S536 | Sugiyama | GALNT2 | NDSRQKWEQIEGNSKLRHVGsNLCLDSRTAKSGGLSVEVCG |
| Q12888 | S1618 | Sugiyama | TP53BP1 | EQYGLGPYEAVtPLtKAADIsLDNLVEGKRKRRsNVssPAt |
| Q12931 | S361 | Sugiyama | TRAP1 HSP75 HSPC5 | SIFYVPDMKPSMFDVSRELGsSVALYSRKVLIQTKATDILP |
| Q13098 | S483 | Sugiyama | GPS1 COPS1 CSN1 | QIHVKsPPREGsQGELtPANsQsRMstNM____________ |
| Q13136 | S338 | Sugiyama | PPFIA1 LIP1 | MEERITTLEKRYLAAQREATsVHDLNDKLENEIANKDSMHR |
| Q13136 | S668 | Sugiyama | PPFIA1 LIP1 | EEKENTEQRAEEIESRVGsGsLDNLGRFRSMssIPPYPAss |
| Q13136 | S763 | Sugiyama | PPFIA1 LIP1 | PssPRALRLDRLHKGALHtVsHEDIRDIRNstGsQDGPVSN |
| Q13188 | S15 | PSP | STK3 KRS1 MST2 | ______MEQPPAPKSKLKKLsEDsLtKQPEEVFDVLEKLGE |
| Q13243 | S153 | Sugiyama | SRSF5 HRS SFRS5 SRP40 | EVTFADAHRPKLNEGVVEFAsYGDLKNAIEKLSGKEINGRK |
| Q13263 | S784 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | DVGRMFKQFNKLTEDKADVQsIIGLQRFFETRMNEAFGDTK |
| Q13283 | S362 | Sugiyama | G3BP1 G3BP | LFIGNLPHEVDKSELKDFFQsyGNVVELRINsGGKLPNFGF |
| Q13347 | S217 | Sugiyama | EIF3I EIF3S2 TRIP1 | sRDMtMFVtASKDNTAKLFDsttLEHQKTFRTERPVNSAAL |
| Q13470 | S502 | SIGNOR | TNK1 | PPARGQRRNMPLERMKGIsRsLEsVLsLGPRPtGGGssPPE |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13625 | S480 | Sugiyama | TP53BP2 ASPP2 BBP | FDAVDQSNAPPSFGTLRKNQssEDILRDAQVANKNVAKVPP |
| Q13733 | S377 | Sugiyama | ATP1A4 ATP1AL2 | KRMARKNCLVKNLEAVETLGstsTICSDKTGTLTQNRMTVA |
| Q13765 | S186 | Sugiyama | NACA HSD48 | sEEEEVDEtGVEVKDIELVMsQANVsRAKAVRALKNNSNDI |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14258 | S340 | Sugiyama | TRIM25 EFP RNF147 ZNF147 | KPVYIPEVELNHKLIKGIHQstIDLKNELKQCIGRLQEPTP |
| Q14432 | T311 | Sugiyama | PDE3A | RsssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKR |
| Q14498 | S334 | Sugiyama | RBM39 HCC1 RNPC2 | FELAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtT |
| Q14568 | S164 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | VAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGT |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14738 | S598 | Sugiyama | PPP2R5D | DVyTIKALEAHKRAEEFLTAsQEAL________________ |
| Q14789 | S1568 | Sugiyama | GOLGB1 | RDKLITEMDRSLLENQSLSssCEsLKLALEGLTEDKEKLVK |
| Q14980 | S1181 | Sugiyama | NUMA1 NMP22 NUMA | DsALEtLQGQLEEKAQELGHsQsALAsAQRELAAFRTKVQD |
| Q15075 | S359 | Sugiyama | EEA1 ZFYVE2 | LHQKDLDCQQLQsRLsAsEtsLHRIHVELSEKGEATQKLKE |
| Q15084 | S377 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | PAMAAINARKMKFALLKGsFsEQGINEFLRELsFGRGstAP |
| Q15121 | S116 | Sugiyama | PEA15 | DtKLtRIPsAKKYKDIIRQPsEEEIIKLAPPPKKA______ |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15185 | S85 | Sugiyama | PTGES3 P23 TEBP | KHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVDFNN |
| Q15276 | S407 | Sugiyama | RABEP1 RAB5EP RABPT5 RABPT5A | GDPFSKSDNDMFKDGLRRAQstDsLGtsGsLQSKALGYNYK |
| Q15276 | T408 | Sugiyama | RABEP1 RAB5EP RABPT5 RABPT5A | DPFSKSDNDMFKDGLRRAQstDsLGtsGsLQSKALGYNYKA |
| Q15293 | S80 | Sugiyama | RCN1 RCN | HEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGDGFVt |
| Q15642 | S296 | Sugiyama | TRIP10 CIP4 STOT STP | FARPGDVEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRS |
| Q15785 | S8 | Sugiyama | TOMM34 URCC3 | _____________MAPKFPDsVEELRAAGNESFRNGQyAEA |
| Q16204 | S325 | Sugiyama | CCDC6 D10S170 TST1 | QRKLQREMERREALCRQLsEsEssLEMDDERYFNEMsAQGL |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16531 | T1125 | Sugiyama | DDB1 XAP1 | MQEVVANLQYDDGSGMKREAtADDLIKVVEELtRIH_____ |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q16719 | S443 | Sugiyama | KYNU | VVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAET |
| Q16836 | S196 | Sugiyama | HADH HAD HAD1 HADHSC SCHAD | PVMKLVEVIKTPMTSQKTFEsLVDFSKALGKHPVSCKDTPG |
| Q3MII6 | S506 | Sugiyama | TBC1D25 OATL1 | DHLATASQGPGGGGRLLRQAsLDGLQQLRDNMGSRRDPLVQ |
| Q3V6T2 | S1702 | Sugiyama | CCDC88A APE GRDN KIAA1212 | TLQQFLEEsNKLTSVQIKsssQENLLDEVMKSLsVssDFLG |
| Q53EL6 | S46 | Sugiyama | PDCD4 H731 | GDEENAGTEEIKNEINGNWIsAssINEARINAKAKRRLRKN |
| Q53ET0 | S171 | GPS6|EPSD | CRTC2 TORC2 | NFPAEKGQLFRLPSALNRtssDsALHtsVMNPsPQDtYPGP |
| Q53ET0 | S274 | GPS6|EPSD | CRTC2 TORC2 | PSPDQPANVPVLPPAMNtGGsLPDLTNLHFPPPLPTPLDPE |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q58FF8 | S266 | Sugiyama | HSP90AB2P HSP90BB | EEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWKRDSRV |
| Q5JSH3 | S565 | Sugiyama | WDR44 RPH11 | DYFNNMRMKYNtEGRVsPsPsQEsLsssKsDTDtGVCsGtD |
| Q5T035 | S66 | Sugiyama | FAM120A2P C9orf129 | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPI |
| Q6EEV6 | S28 | Sugiyama | SUMO4 SMT3H4 | EEVKTENNNHINLKVAGQDGsVVQFKIKRQTPLSKLMKAYC |
| Q6GYQ0 | T798 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | tGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDMS |
| Q6NVY1 | S381 | Sugiyama | HIBCH | PADLKEVtEEDLNNHFKSLGsSDLKF_______________ |
| Q6P1J9 | S178 | Sugiyama | CDC73 C1orf28 HRPT2 | EGHKEGIVQTEQIRSLsEAMsVEKIAAIKAKIMAKKRSTIK |
| Q6P2E9 | S967 | Sugiyama | EDC4 HEDLS | PEDWPALIWQQQRELAELRHsQEELLQRLCTQLEGLQSTVT |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6WKZ4 | S234 | SIGNOR|PSP | RAB11FIP1 RCP | KSKIKTLLsKSNLQKtPLsQsMsVLPTsKPEKVLLRPGDFQ |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q7KZI7 | S40 | Sugiyama | MARK2 EMK1 | TLGHLDSKPssKSNMIRGRNsAtsADEQPHIGNyRLLKTIG |
| Q7KZI7 | S400 | EPSD|PSP | MARK2 EMK1 | sADLtNssAPsPsHKVQRsVsANPKQRRFsDQAAGPAIPTS |
| Q7KZI7 | S43 | Sugiyama | MARK2 EMK1 | HLDSKPssKSNMIRGRNsAtsADEQPHIGNyRLLKTIGKGN |
| Q7KZI7 | S448 | Sugiyama | MARK2 EMK1 | QSNNAENKRPEEDRESGRKAsstAKVPAsPLPGLERKKttP |
| Q7KZI7 | S449 | Sugiyama | MARK2 EMK1 | SNNAENKRPEEDRESGRKAsstAKVPAsPLPGLERKKttPt |
| Q7KZI7 | S456 | Sugiyama | MARK2 EMK1 | RPEEDRESGRKAsstAKVPAsPLPGLERKKttPtPstNSVL |
| Q7KZI7 | S471 | Sugiyama | MARK2 EMK1 | AKVPAsPLPGLERKKttPtPstNSVLststNRsRNsPLLER |
| Q7KZI7 | S486 | Sugiyama | MARK2 EMK1 | ttPtPstNSVLststNRsRNsPLLERAsLGQAsIQNGKDSL |
| Q7KZI7 | S493 | Sugiyama | MARK2 EMK1 | NSVLststNRsRNsPLLERAsLGQAsIQNGKDSLTMPGSRA |
| Q7KZI7 | S498 | Sugiyama | MARK2 EMK1 | tstNRsRNsPLLERAsLGQAsIQNGKDSLTMPGSRAstAsA |
| Q7KZI7 | S514 | Sugiyama | MARK2 EMK1 | LGQAsIQNGKDSLTMPGSRAstAsASAAVSAARPRQHQKsM |
| Q7KZI7 | S517 | Sugiyama | MARK2 EMK1 | AsIQNGKDSLTMPGSRAstAsASAAVSAARPRQHQKsMsAs |
| Q7KZI7 | S551 | Sugiyama | MARK2 EMK1 | QKsMsAsVHPNKASGLPPTEsNCEVPRPstAPQRVPVAsPs |
| Q7KZI7 | S569 | Sugiyama | MARK2 EMK1 | TEsNCEVPRPstAPQRVPVAsPsAHNIsssGGAPDRTNFPR |
| Q7KZI7 | S571 | Sugiyama | MARK2 EMK1 | sNCEVPRPstAPQRVPVAsPsAHNIsssGGAPDRTNFPRGV |
| Q7KZI7 | S576 | Sugiyama | MARK2 EMK1 | PRPstAPQRVPVAsPsAHNIsssGGAPDRTNFPRGVssRst |
| Q7KZI7 | S578 | Sugiyama | MARK2 EMK1 | PstAPQRVPVAsPsAHNIsssGGAPDRTNFPRGVssRstFH |
| Q7KZI7 | S592 | Sugiyama | MARK2 EMK1 | AHNIsssGGAPDRTNFPRGVssRstFHAGQLRQVRDQQNLP |
| Q7KZI7 | S593 | Sugiyama | MARK2 EMK1 | HNIsssGGAPDRTNFPRGVssRstFHAGQLRQVRDQQNLPy |
| Q7KZI7 | S595 | Sugiyama | MARK2 EMK1 | IsssGGAPDRTNFPRGVssRstFHAGQLRQVRDQQNLPyGV |
| Q7KZI7 | S619 | Sugiyama | MARK2 EMK1 | AGQLRQVRDQQNLPyGVtPAsPsGHsQGRRGAsGsIFSKFT |
| Q7KZI7 | S621 | Sugiyama | MARK2 EMK1 | QLRQVRDQQNLPyGVtPAsPsGHsQGRRGAsGsIFSKFTSK |
| Q7KZI7 | S631 | Sugiyama | MARK2 EMK1 | LPyGVtPAsPsGHsQGRRGAsGsIFSKFTSKFVRRNLSFRF |
| Q7KZI7 | S633 | Sugiyama | MARK2 EMK1 | yGVtPAsPsGHsQGRRGAsGsIFSKFTSKFVRRNLSFRFAR |
| Q7KZI7 | S704 | Sugiyama | MARK2 EMK1 | EFREAKPRSLRFTWSMKTTSsMEPNEMMREIRKVLDANsCQ |
| Q7KZI7 | S722 | Sugiyama | MARK2 EMK1 | TSsMEPNEMMREIRKVLDANsCQSELHEKYMLLCMHGTPGH |
| Q7KZI7 | S759 | Sugiyama | MARK2 EMK1 | TPGHEDFVQWEMEVCKLPRLsLNGVRFKRISGTSMAFKNIA |
| Q7KZI7 | S93 | Sugiyama | MARK2 EMK1 | ILTGKEVAVKIIDKTQLNSSsLQKLFREVRIMKVLNHPNIV |
| Q7KZI7 | T42 | Sugiyama | MARK2 EMK1 | GHLDSKPssKSNMIRGRNsAtsADEQPHIGNyRLLKTIGKG |
| Q7KZI7 | T450 | Sugiyama | MARK2 EMK1 | NNAENKRPEEDRESGRKAsstAKVPAsPLPGLERKKttPtP |
| Q7KZI7 | T469 | Sugiyama | MARK2 EMK1 | stAKVPAsPLPGLERKKttPtPstNSVLststNRsRNsPLL |
| Q7KZI7 | T515 | Sugiyama | MARK2 EMK1 | GQAsIQNGKDSLTMPGSRAstAsASAAVSAARPRQHQKsMs |
| Q7KZI7 | T596 | Sugiyama | MARK2 EMK1 | sssGGAPDRTNFPRGVssRstFHAGQLRQVRDQQNLPyGVt |
| Q7KZI7 | T616 | Sugiyama | MARK2 EMK1 | tFHAGQLRQVRDQQNLPyGVtPAsPsGHsQGRRGAsGsIFS |
| Q7KZI7 | Y613 | Sugiyama | MARK2 EMK1 | sRstFHAGQLRQVRDQQNLPyGVtPAsPsGHsQGRRGAsGs |
| Q7L2H7 | S367 | Sugiyama | EIF3M HFLB5 PCID1 GA17 PNAS-125 | WQQLyDTLNAWKQNLNKVKNsLLsLsDt_____________ |
| Q7L804 | S227 | GPS6|SIGNOR|EPSD|PSP | RAB11FIP2 KIAA0941 | MKSKPKKPFLLGPQRLSsAHsMsDLSGSHMSSEKLKAGTIG |
| Q7Z2W4 | S492 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | VQATGRIADDADPRVALVNDsLsDVtsTtssRVDDHDSEEI |
| Q7Z2W4 | S494 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | ATGRIADDADPRVALVNDsLsDVtsTtssRVDDHDSEEICL |
| Q7Z417 | S655 | Sugiyama | NUFIP2 KIAA1321 PIG1 | LGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsIWNL |
| Q7Z417 | S671 | Sugiyama | NUFIP2 KIAA1321 PIG1 | DsWGsFDLRAAIVYHTKEMEsIWNLQKQDPKRIItyNEAMD |
| Q7Z460 | S1193 | Sugiyama | CLASP1 KIAA0622 MAST1 | LNSEEIYSSLRGVTEAIEKFsFRsQEDLNEPIKRDGKKECD |
| Q7Z460 | S545 | Sugiyama | CLASP1 KIAA0622 MAST1 | yHTLESSyQKALQSHLKNSDsIVsLPQsDRsssssQEsLNR |
| Q86TC9 | S198 | Sugiyama | MYPN MYOP | CKNHKSKLESQNKVMQENSssFsDLSERRERSSVPIPIPAD |
| Q86UF2 | S140 | Sugiyama | CTAGE6 CTAGE6P | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q86V81 | S239 | Sugiyama | ALYREF ALY BEF THOC4 | tRGGARGRGRGAGRNSKQQLsAEELDAQLDAyNARMDts__ |
| Q86V81 | S8 | Sugiyama | ALYREF ALY BEF THOC4 | _____________MADKMDMsLDDIIKLNRSQRGGRGGGRG |
| Q86VQ1 | S226 | Sugiyama | GLCCI1 | sCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQRSKQ |
| Q86W92 | S636 | Sugiyama | PPFIBP1 KIAA1230 | RGGTRATAGPRLGWsRDLGQsNsDLDMPFAKWTKEQVCNWL |
| Q8IX94 | S140 | Sugiyama | CTAGE4 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q8IZP0 | S22 | Sugiyama | ABI1 SSH3BP1 | AELQMLLEEEIPSGKRALIEsyQNLTRVADyCENNyIQATD |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8TDD1 | S644 | Sugiyama | DDX54 | sRPALQEKQPEKEEEEEAGEsVEDIFSEVVGRKRQRSGPNR |
| Q8TEW0 | S144 | EPSD|PSP | PARD3 PAR3 PAR3A | EIEVTPSVLRANMPLHVRRssDPALIGLstsVsDsNFSSEE |
| Q8TEW0 | S873 | SIGNOR|EPSD|PSP | PARD3 PAR3 PAR3A | MDLGIADETKLNTVDDQKAGsPsRDVGPSLGLKKsssLEsL |
| Q8WU90 | S351 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | DIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLsEAs |
| Q8WU90 | T348 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | sVNDIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLs |
| Q8WUI4 | S155 | SIGNOR|ELM|EPSD|PSP | HDAC7 HDAC7A | PPVPSLPSDPPEHFPLRKtVsEPNLKLRYKPKKSLERRKNP |
| Q8WWH5 | S268 | Sugiyama | TRUB1 PUS4 | ECGGGFYIRSLVSDIGKELSsCANVLELTRTKQGPFTLEEH |
| Q8WWI1 | S1423 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | IPKTEEAsSGFLPGDRNKsRsttELDDYSTNKNGNNKYLDQ |
| Q8WWI1 | S1510 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | RsAsVNKEPVSLPGIMRRGEsLDNLDsPRSNSWRQPPWLNQ |
| Q8WWI1 | S706 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | RLMVERLFQKIYGENGsKsMsDVsAEDVQNLRQLRYEEMQK |
| Q92609 | S541 | Sugiyama | TBC1D5 KIAA0210 | EsMPVQLNKGLSSKNIsssPsVEsLPGGREFtGsPPssAtK |
| Q92973 | S339 | Sugiyama | TNPO1 KPNB2 MIP1 TRN | SDIDIILLKGDVEEDEtIPDsEQDIRPRFHRSRTVAQQHDE |
| Q92974 | S143 | EPSD|PSP | ARHGEF2 KIAA0651 LFP40 | AIyPsDsFRQsLLGsRRGRssLSLAKsVsttNIAGHFNDEs |
| Q92974 | S172 | EPSD|PSP | ARHGEF2 KIAA0651 LFP40 | ttNIAGHFNDEsPLGLRRILsQstDsLNMRNRTLsVESLID |
| Q92974 | S174 | Sugiyama | ARHGEF2 KIAA0651 LFP40 | NIAGHFNDEsPLGLRRILsQstDsLNMRNRTLsVESLIDEA |
| Q92974 | S186 | EPSD|PSP | ARHGEF2 KIAA0651 LFP40 | GLRRILsQstDsLNMRNRTLsVESLIDEAEVIySELMSDFE |
| Q92974 | S711 | Sugiyama | ARHGEF2 KIAA0651 LFP40 | sGGNtsPGVtANGEARTFNGsIELCRADsDssQRDRNGNQL |
| Q92974 | S886 | SIGNOR | ARHGEF2 KIAA0651 LFP40 | TEPLPAEAPWARRPVDPRRRsLPAGDALyLsFNPPQPSRGT |
| Q92974 | S960 | SIGNOR | ARHGEF2 KIAA0651 LFP40 | ssDPDtGsEEEGssRLsPPHsPRDFtRMQDIPEEtEsRDGE |
| Q96A72 | S108 | Sugiyama | MAGOHB MAGOH2 | QELEIVIGDEHISFTTSKIGsLIDVNQSKDPEGLRVFYYLV |
| Q96CT7 | S122 | Sugiyama | CCDC124 | DtLRRDHQLREAPDTAEKAKsHLEVPLEENVNRRVLEEGsV |
| Q96D15 | S98 | Sugiyama | RCN3 UNQ239/PRO272 | ARLGRIVDRMDRAGDGDGWVsLAELRAWIAHTQQRHIRDsV |
| Q96N67 | S1438 | Sugiyama | DOCK7 KIAA1771 | LGTYTIAsPPERsPsGsAFGsQENLRWRKDMTHWRQNTEKL |
| Q96P16 | S285 | Sugiyama | RPRD1A P15RS | YKRKLARVSLVRKELRSRIQsLPDLSRLPNVTGSHMHLPFA |
| Q96PK6 | S520 | Sugiyama | RBM14 SIP | AAAAYGAQPSATLAAPYRtQssAsLAAsYAAQQHPQAAASY |
| Q96PK6 | S620 | Sugiyama | RBM14 SIP | KRYGSDRRLAELsDYRRLsEsQLsFRRsPtKSSLDYRRLPD |
| Q96S59 | S181 | Sugiyama | RANBP9 RANBPM | QEtPLPRSWsPKDKFsYIGLsQNNLRVHYKGHGKTPKDAAS |
| Q96S59 | S613 | Sugiyama | RANBP9 RANBPM | DCDtEMEVDSsQLRRQLCGGsQAAIERMIHFGRELQAMSEQ |
| Q99426 | S163 | Sugiyama | TBCB CG22 CKAP1 | AEAAQRLAEEKAQASSIPVGsRCEVRAAGQSPRRGTVMYVG |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99689 | S58 | EPSD|PSP | FEZ1 | LEDPSLSELENFSSEIISFKsMEDLVNEFDEKLNVCFRNYN |
| Q9BQL6 | S253 | Sugiyama | FERMT1 C20orf42 KIND1 URP1 | DMYQPRSLVDKAKLNAGWLDsSRSLMEQGIQEDEQLLLRFK |
| Q9BS40 | S41 | Sugiyama | LXN | INyQQGTPHRVFEVQKVKQAsMEDIPGRGHKYHLKFAVEEI |
| Q9BT78 | S18 | Sugiyama | COPS4 CSN4 | ___MAAAVRQDLAQLMNSsGsHKDLAGKYRQILEKAIQLSG |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BW91 | S343 | Sugiyama | NUDT9 NUDT10 PSEC0099 UNQ3012/PRO9771 | SHSQFIKLVAEKRDAHWSEDsEADCHAL_____________ |
| Q9BX40 | S165 | Sugiyama | LSM14B C20orf40 FAM61B RAP55B | GFPSIPVGKsPMVEQAVQtGsADNLNAKKLLPGKGTTGTQL |
| Q9BXM7 | T313 | SIGNOR|EPSD|PSP | PINK1 | VDYPDVLPSRLHPEGLGHGRtLFLVMKNYPCTLRQYLCVNT |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BZ72 | S644 | Sugiyama | PITPNM2 KIAA1457 NIR3 | SGGGGSSGGSSLESSRHLsRsNVDIPRSNGTEDPKRQLPRK |
| Q9C0C2 | S1158 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | sPssKMEGGHFVPPGKttAGsVDWTDQLGLRNLEVssCVGs |
| Q9C0C7 | S628 | Sugiyama | AMBRA1 DCAF3 KIAA1736 | SVPSSGSQLPPLERTEGQTPsSsRLELsssAsPQEERTVGV |
| Q9C0C7 | S630 | Sugiyama | AMBRA1 DCAF3 KIAA1736 | PSSGSQLPPLERTEGQTPsSsRLELsssAsPQEERTVGVAF |
| Q9H0H5 | S257 | Sugiyama | RACGAP1 KIAA1478 MGCRACGAP | ETVPYWtRSRRKtGtLQPWNsDstLNSRQLEPRTETDsVGt |
| Q9H1H9 | S1698 | Sugiyama | KIF13A RBKIN | GsPSSQSIPEKNSKSLCRtGsCsELDACPSKISQPARGFCP |
| Q9H2G2 | S340 | Sugiyama | SLK KIAA0204 STK2 | EEDEEEEtENsLPIPAsKRAssDLsIAssEEDKLsQNACIL |
| Q9H4P4 | S254 | EPSD|PSP | RNF41 FLRF NRDP1 SBBI03 | VESGCPASIVNELIENAHERsWPQGLATLETRQMNRRYYEN |
| Q9H7D7 | S123 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | SSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLNQT |
| Q9H7E9 | T40 | Sugiyama | C8orf33 | PCAsRGARLPGPVsSARNPstVCLCPEQPTCSNADSRAHPL |
| Q9HA77 | S548 | Sugiyama | CARS2 OK/SW-cl.10 | TLRRGLTAHGINIKDRssttstWELLDQRTKDQKSAG____ |
| Q9HAP6 | S120 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | DEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLKRGDQL |
| Q9HAU0 | S410 | Sugiyama | PLEKHA5 KIAA1686 PEPP2 | NRPNTGPLytEADRVIQRtNsMQQLEQWIKIQKGRGHEEET |
| Q9HCN4 | S301 | Sugiyama | GPN1 MBDIN RPAP4 XAB1 HUSSY-23 | ANAESQQQREQLERLRKDMGsVALDAGtAKDsLsPVLHPsD |
| Q9HCN8 | S40 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | ALLVPGGGAAKTGAELVTCGsVLKLLNTHHRVRLHSHDIKY |
| Q9NP61 | S457 | Sugiyama | ARFGAP3 ARFGAP1 | sQADYETRARLERLsAsssIssADLFEEPRKQPAGNysLSS |
| Q9NPF0 | S142 | Sugiyama | CD320 8D6A UNQ198/PRO224 | KKLRNCSRLACLAGELRCTLsDDCIPLTWRCDGHPDCPDSS |
| Q9NQT8 | S1381 | GPS6|SIGNOR|EPSD|PSP | KIF13B GAKIN KIAA0639 | QEVAVKEQLTGKGKLSRRsIssPNVNRLsGsRQDLIPsYSL |
| Q9NQT8 | S1410 | GPS6|SIGNOR|EPSD|PSP | KIF13B GAKIN KIAA0639 | GsRQDLIPsYSLGSNKGRWEsQQDVSQTTVSRGIAPAPALs |
| Q9NQX3 | S303 | Sugiyama | GPHN GPH KIAA1385 | sCPtPKVQSRCSsKENILRAsHsAVDITKVARRHRMSPFPL |
| Q9NQX3 | S305 | Sugiyama | GPHN GPH KIAA1385 | PtPKVQSRCSsKENILRAsHsAVDITKVARRHRMSPFPLTS |
| Q9NTJ3 | S504 | Sugiyama | SMC4 CAPC SMC4L1 | ELMGFSKSVNEARSKMDVAQsELDIyLSRHNTAVSQLTKAK |
| Q9NUP9 | S120 | Sugiyama | LIN7C MALS3 VELI3 | EEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLKRGDQL |
| Q9NW64 | S142 | Sugiyama | RBM22 ZC3H16 199G4 | EREISNsDGTRPVGMLGKATsTsDMLLKLARTTPYYKRNRP |
| Q9NYB9 | S22 | Sugiyama | ABI2 ARGBPIA | AELQMLLEEEIPGGRRALFDsytNLERVADyCENNyIQSAD |
| Q9NZB2 | S417 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPI |
| Q9P0L2 | S766 | Sugiyama | MARK1 KIAA1477 MARK | DARQDSLVQWEMEVCKLPRLsLNGVRFKRISGTSIAFKNIA |
| Q9P1Y5 | S431 | Sugiyama | CAMSAP3 KIAA1543 | FGLDSDVDVVMGDPVLLRsVssDsLGPPRPAPARTPtQPPP |
| Q9P265 | S203 | Sugiyama | DIP2B KIAA1463 | stsssASSTLSHGEVKGtsGsLADVFANtRIENFSAPPDVT |
| Q9UBU9 | S223 | Sugiyama | NXF1 TAP | ELKPEQVEQLKLIMSKRYDGsQQALDLKGLRSDPDLVAQNI |
| Q9UGU0 | S1187 | Sugiyama | TCF20 KIAA0292 SPBP | sDGLPNKGMELKHGSQKLQEsCWDLsRQTsPAKSSGPPGMS |
| Q9UGV2 | S333 | Sugiyama | NDRG3 | MGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsD |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9UHR4 | S354 | Sugiyama | BAIAP2L1 IRTKS | TGLNMMKKQKVKTIFPHtAGsNKTLLSFAQGDVITLLIPEE |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UII2 | S63 | Sugiyama | ATP5IF1 ATPI ATPIF1 | AGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEIVHHKK |
| Q9UJF2 | S803 | Sugiyama | RASAL2 NGAP | NPVyHLNNPIPAMPKASIDssLENLSTAssRSQSNSEDFKL |
| Q9UNZ2 | S189 | Sugiyama | NSFL1C UBXN2C | AGEKRQHssQDVHVVLKLWKsGFsLDNGELRSyQDPsNAQF |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9UQ35 | S1539 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sEssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEs |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQ80 | T377 | Sugiyama | PA2G4 EBP1 | LLQssAsRKtQKKKKKKAsKtAENAtsGEtLEENEAGD___ |
| Q9UQB8 | S366 | EPSD|PSP | BAIAP2 | SVTPKNSYATtENKtLPRsssMAAGLERNGRMRVKAIFsHA |
| Q9UQL6 | S259 | EPSD|PSP | HDAC5 KIAA0600 | KLPLPGPYDSRDDFPLRKTAsEPNLKVRSRLKQKVAERRss |
| Q9Y262 | S80 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | HKTVSDLIDQKVYELQASRVssDVIDQKVyEIQDIyENSWT |
| Q9Y262 | S81 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | KTVSDLIDQKVYELQASRVssDVIDQKVyEIQDIyENSWTK |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2B0 | T79 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NPDGsQsVVEVPyARsEAHLtELLEEICDRMKEyGEQIDPs |
| Q9Y2L1 | S633 | Sugiyama | DIS3 KIAA1008 RRP44 | LNKLAKILKKRRIEKGALTLssPEVRFHMDSETHDPIDLQT |
| Q9Y316 | S91 | Sugiyama | MEMO1 C2orf4 MEMO NS5ATP7 CGI-27 | TRRIFILGPSHHVPLsRCALsSVDIYRTPLYDLRIDQKIYG |
| Q9Y3F4 | S254 | Sugiyama | STRAP MAWD UNRIP | EKEFLVAGGEDFKLyKyDyNsGEELEsyKGHFGPIHCVRFS |
| Q9Y3S2 | S25 | Sugiyama | ZNF330 NOA36 | KTGARKKAENRREREKQLRAsRstIDLAKHPCNASMECDKC |
| Q9Y3S2 | S27 | Sugiyama | ZNF330 NOA36 | GARKKAENRREREKQLRAsRstIDLAKHPCNASMECDKCQR |
| Q9Y3S2 | T28 | Sugiyama | ZNF330 NOA36 | ARKKAENRREREKQLRAsRstIDLAKHPCNASMECDKCQRR |
| Q9Y450 | S69 | Sugiyama | HBS1L HBS1 KIAA1038 | sVEPVEEyDyEDLKEssNsVsNHQLSGFDQARLYsCLDHMR |
| Q9Y490 | S1535 | Sugiyama | TLN1 KIAA1027 TLN | RTTNPTAKRQFVQSAKEVANsTANLVKTIKALDGAFTEENR |
| Q9Y4G6 | S1537 | Sugiyama | TLN2 KIAA0320 | KTANPVAKRHFVQSAKEVANsTANLVKTIKALDGDFSEDNR |
| Q9Y4L1 | S742 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | KLQDLTLRDLEKQEREKAANsLEAFIFEtQDKLyQPEyQEV |
| Q9Y4L1 | T750 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | DLEKQEREKAANsLEAFIFEtQDKLyQPEyQEVsTEEQREE |
| Q9Y5K5 | S133 | Sugiyama | UCHL5 UCH37 AD-019 CGI-70 | EFKEFSQSFDAAMKGLALsNsDVIRQVHNSFARQQMFEFDT |
| Q9Y696 | S226 | Sugiyama | CLIC4 | RNFDIPKEMTGIWRYLtNAysRDEFtNtCPsDKEVEIAysD |
| Q9Y6E0 | S400 | Sugiyama | STK24 MST3 STK3 | ISPLFAELKEKsQACGGNLGsIEELRGAIYLAEEACPGISD |
| Q9Y6Y8 | T893 | Sugiyama | SEC23IP MSTP053 | GFISSLKSAWQTLNEFARAHtsstQLQEELEKVANQIKEEE |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 2.832934e-09 | 8.548 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.559998e-08 | 7.449 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 9.318238e-08 | 7.031 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 9.832098e-08 | 7.007 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.735929e-07 | 6.563 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.565409e-07 | 6.591 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.954158e-07 | 6.305 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.954158e-07 | 6.305 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.729098e-07 | 6.325 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.015725e-06 | 5.993 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.288949e-06 | 5.483 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.256394e-06 | 5.279 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.477042e-06 | 5.189 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 7.534151e-06 | 5.123 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.294366e-05 | 4.888 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.293970e-05 | 4.888 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.675340e-05 | 4.776 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.419337e-05 | 4.616 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.926634e-05 | 4.406 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.989403e-05 | 4.302 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.989403e-05 | 4.302 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.834122e-05 | 4.316 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 9.862647e-05 | 4.006 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.101234e-04 | 3.958 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.224685e-04 | 3.912 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.251969e-04 | 3.902 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.299608e-04 | 3.886 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.520316e-04 | 3.818 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.763488e-04 | 3.754 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.233559e-04 | 3.651 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.174149e-04 | 3.663 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.666859e-04 | 3.574 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.028826e-04 | 3.519 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.028826e-04 | 3.519 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.148013e-04 | 3.502 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.675345e-04 | 3.435 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.842533e-04 | 3.415 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.894685e-04 | 3.410 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.257179e-04 | 3.371 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.572583e-04 | 3.340 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.926476e-04 | 3.307 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 6.070093e-04 | 3.217 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 6.070093e-04 | 3.217 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 6.568339e-04 | 3.183 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.813702e-04 | 3.167 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.117666e-04 | 3.148 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.489625e-04 | 3.126 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 7.787301e-04 | 3.109 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.667860e-04 | 3.062 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 9.459281e-04 | 3.024 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 9.459281e-04 | 3.024 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 9.459281e-04 | 3.024 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 9.459736e-04 | 3.024 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 9.459281e-04 | 3.024 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 9.736713e-04 | 3.012 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.931416e-04 | 3.049 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.075649e-03 | 2.968 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.091005e-03 | 2.962 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.160535e-03 | 2.935 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.139511e-03 | 2.943 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.485612e-03 | 2.828 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.435588e-03 | 2.843 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.465603e-03 | 2.834 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.449193e-03 | 2.839 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.422505e-03 | 2.847 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.569581e-03 | 2.804 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.576383e-03 | 2.802 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.707442e-03 | 2.768 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.702505e-03 | 2.769 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.817956e-03 | 2.740 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.817956e-03 | 2.740 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.832579e-03 | 2.737 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.850506e-03 | 2.733 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.915778e-03 | 2.718 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.966796e-03 | 2.706 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.969802e-03 | 2.706 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.004811e-03 | 2.698 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.075380e-03 | 2.683 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.081757e-03 | 2.682 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.251278e-03 | 2.648 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.276178e-03 | 2.643 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.283278e-03 | 2.641 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.538406e-03 | 2.595 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.584976e-03 | 2.588 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.630637e-03 | 2.580 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.038901e-03 | 2.517 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.061961e-03 | 2.514 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.290034e-03 | 2.483 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.319531e-03 | 2.479 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.353295e-03 | 2.475 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.490406e-03 | 2.457 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.502842e-03 | 2.456 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.546486e-03 | 2.450 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.124607e-03 | 2.385 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.768368e-03 | 2.322 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.348293e-03 | 2.362 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.896277e-03 | 2.310 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.779237e-03 | 2.321 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.011920e-03 | 2.300 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.580805e-03 | 2.339 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.580805e-03 | 2.339 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.580805e-03 | 2.339 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.266513e-03 | 2.370 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.098644e-03 | 2.293 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 5.282559e-03 | 2.277 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.542427e-03 | 2.256 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.542427e-03 | 2.256 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.926846e-03 | 2.227 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.926846e-03 | 2.227 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 6.894791e-03 | 2.161 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.444609e-03 | 2.191 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.007039e-03 | 2.154 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 7.082900e-03 | 2.150 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.082900e-03 | 2.150 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 7.193473e-03 | 2.143 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 7.601040e-03 | 2.119 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.920610e-03 | 2.101 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.435413e-03 | 2.074 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.448336e-03 | 2.073 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.977473e-03 | 2.098 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.977473e-03 | 2.098 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.332591e-03 | 2.079 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.030054e-03 | 2.095 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.593969e-03 | 2.066 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 8.574076e-03 | 2.067 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.274515e-03 | 2.033 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.593969e-03 | 2.066 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.351646e-03 | 2.029 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.593969e-03 | 2.066 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 9.121231e-03 | 2.040 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.164224e-03 | 2.038 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.511117e-03 | 2.022 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.705101e-03 | 2.013 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 9.881082e-03 | 2.005 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.984256e-03 | 2.001 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.044455e-02 | 1.981 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.048025e-02 | 1.980 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.106052e-02 | 1.956 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.106052e-02 | 1.956 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.106052e-02 | 1.956 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.106052e-02 | 1.956 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.123029e-02 | 1.950 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.113804e-02 | 1.953 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.154333e-02 | 1.938 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.166633e-02 | 1.933 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.157123e-02 | 1.937 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.174773e-02 | 1.930 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.174773e-02 | 1.930 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.257115e-02 | 1.901 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.269785e-02 | 1.896 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.289157e-02 | 1.890 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.301743e-02 | 1.885 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.307013e-02 | 1.884 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.361551e-02 | 1.866 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 1.364019e-02 | 1.865 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.480663e-02 | 1.830 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.449539e-02 | 1.839 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.510410e-02 | 1.821 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.416780e-02 | 1.849 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.534697e-02 | 1.814 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.480663e-02 | 1.830 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.534697e-02 | 1.814 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.527030e-02 | 1.816 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.560070e-02 | 1.807 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.580672e-02 | 1.801 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.580672e-02 | 1.801 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.582414e-02 | 1.801 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.582414e-02 | 1.801 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.633970e-02 | 1.787 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.717504e-02 | 1.765 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.726994e-02 | 1.763 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.737922e-02 | 1.760 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.986065e-02 | 1.702 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.986065e-02 | 1.702 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.986065e-02 | 1.702 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.986065e-02 | 1.702 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.986065e-02 | 1.702 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.986065e-02 | 1.702 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.986065e-02 | 1.702 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.986065e-02 | 1.702 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.986065e-02 | 1.702 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.986065e-02 | 1.702 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.986065e-02 | 1.702 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 1.836992e-02 | 1.736 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.829047e-02 | 1.738 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.829047e-02 | 1.738 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.925382e-02 | 1.715 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.111065e-02 | 1.675 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.120923e-02 | 1.673 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.129852e-02 | 1.672 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.132088e-02 | 1.671 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.170677e-02 | 1.663 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.186827e-02 | 1.660 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.186827e-02 | 1.660 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.286044e-02 | 1.641 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.345662e-02 | 1.630 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.354147e-02 | 1.628 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.369651e-02 | 1.625 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.445731e-02 | 1.612 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 2.546137e-02 | 1.594 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.598654e-02 | 1.585 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.940632e-02 | 1.532 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.940632e-02 | 1.532 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.798111e-02 | 1.553 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.806862e-02 | 1.552 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.994101e-02 | 1.524 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.798111e-02 | 1.553 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.994101e-02 | 1.524 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.765358e-02 | 1.558 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.940632e-02 | 1.532 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.784767e-02 | 1.555 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.876768e-02 | 1.541 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.140245e-02 | 1.503 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.195890e-02 | 1.495 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.197338e-02 | 1.495 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.410707e-02 | 1.467 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.410707e-02 | 1.467 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 3.923044e-02 | 1.406 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.923044e-02 | 1.406 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.471049e-02 | 1.460 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.471049e-02 | 1.460 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.923044e-02 | 1.406 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.737753e-02 | 1.427 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.880977e-02 | 1.411 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.448429e-02 | 1.462 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.588494e-02 | 1.445 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.994615e-02 | 1.399 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.937555e-02 | 1.405 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.451853e-02 | 1.462 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.004140e-02 | 1.397 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 4.041940e-02 | 1.393 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.094949e-02 | 1.388 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.097002e-02 | 1.388 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.097002e-02 | 1.388 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.135136e-02 | 1.384 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 4.135136e-02 | 1.384 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.140225e-02 | 1.383 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.213380e-02 | 1.375 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.247093e-02 | 1.372 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.330501e-02 | 1.363 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.407528e-02 | 1.356 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.418640e-02 | 1.355 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.509386e-02 | 1.346 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.509386e-02 | 1.346 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 5.083316e-02 | 1.294 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.783421e-02 | 1.320 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.444834e-02 | 1.264 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.444834e-02 | 1.264 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.444834e-02 | 1.264 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.444834e-02 | 1.264 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.690560e-02 | 1.329 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.080430e-02 | 1.294 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.761796e-02 | 1.322 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.839391e-02 | 1.315 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.444834e-02 | 1.264 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 4.783421e-02 | 1.320 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.312241e-02 | 1.275 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.128217e-02 | 1.290 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.235032e-02 | 1.281 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.444834e-02 | 1.264 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.362303e-02 | 1.271 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.989559e-02 | 1.302 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.989559e-02 | 1.302 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.304443e-02 | 1.275 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.869455e-02 | 1.313 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 5.038859e-02 | 1.298 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 4.783421e-02 | 1.320 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.167490e-02 | 1.287 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.465836e-02 | 1.262 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.507079e-02 | 1.259 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.527659e-02 | 1.257 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 5.533401e-02 | 1.257 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.533401e-02 | 1.257 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 5.533401e-02 | 1.257 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.564958e-02 | 1.255 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.643911e-02 | 1.248 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.736757e-02 | 1.241 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.778411e-02 | 1.238 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.810366e-02 | 1.236 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.868983e-02 | 1.231 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.868983e-02 | 1.231 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.936435e-02 | 1.226 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.040015e-02 | 1.219 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.050060e-02 | 1.218 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.060583e-02 | 1.217 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 6.191335e-02 | 1.208 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 6.218293e-02 | 1.206 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.218293e-02 | 1.206 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 6.819457e-02 | 1.166 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 6.819457e-02 | 1.166 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 6.819457e-02 | 1.166 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 7.847681e-02 | 1.105 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 7.847681e-02 | 1.105 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 7.847681e-02 | 1.105 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.281545e-02 | 1.138 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.281545e-02 | 1.138 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.281545e-02 | 1.138 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.281545e-02 | 1.138 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.423878e-02 | 1.192 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.423878e-02 | 1.192 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 6.423878e-02 | 1.192 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 6.423878e-02 | 1.192 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.943530e-02 | 1.100 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 7.943530e-02 | 1.100 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.943530e-02 | 1.100 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.943530e-02 | 1.100 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.943530e-02 | 1.100 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.943530e-02 | 1.100 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.943530e-02 | 1.100 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.757352e-02 | 1.170 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.799603e-02 | 1.168 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.799603e-02 | 1.168 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.799603e-02 | 1.168 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.799603e-02 | 1.168 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.799603e-02 | 1.168 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.474774e-02 | 1.189 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.409037e-02 | 1.130 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.409037e-02 | 1.130 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.402864e-02 | 1.131 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.618397e-02 | 1.118 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 6.681935e-02 | 1.175 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 6.681935e-02 | 1.175 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.423878e-02 | 1.192 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 6.474774e-02 | 1.189 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.519737e-02 | 1.186 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.563085e-02 | 1.121 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.876405e-02 | 1.104 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.943530e-02 | 1.100 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.757352e-02 | 1.170 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.725406e-02 | 1.112 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.799603e-02 | 1.168 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.618397e-02 | 1.118 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 6.423878e-02 | 1.192 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 7.052077e-02 | 1.152 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.618397e-02 | 1.118 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 6.423878e-02 | 1.192 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.762561e-02 | 1.170 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.643080e-02 | 1.117 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.876405e-02 | 1.104 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.944528e-02 | 1.100 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.968909e-02 | 1.099 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.968909e-02 | 1.099 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.972746e-02 | 1.098 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.123649e-02 | 1.090 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 8.308002e-02 | 1.081 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 8.369027e-02 | 1.077 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.422111e-02 | 1.075 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.422111e-02 | 1.075 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.422111e-02 | 1.075 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.422111e-02 | 1.075 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.422111e-02 | 1.075 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 8.472000e-02 | 1.072 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.729275e-02 | 1.059 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.729275e-02 | 1.059 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.729275e-02 | 1.059 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.786047e-02 | 1.056 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 8.810771e-02 | 1.055 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.979128e-02 | 1.047 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.041952e-02 | 1.044 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.107744e-01 | 0.956 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 1.107744e-01 | 0.956 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 1.107744e-01 | 0.956 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 1.107744e-01 | 0.956 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 1.107744e-01 | 0.956 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.107744e-01 | 0.956 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 1.060079e-01 | 0.975 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 1.060079e-01 | 0.975 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.060079e-01 | 0.975 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 9.275405e-02 | 1.033 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 9.275405e-02 | 1.033 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 9.275405e-02 | 1.033 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.149839e-01 | 0.939 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.149839e-01 | 0.939 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.149839e-01 | 0.939 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 9.637726e-02 | 1.016 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 9.551183e-02 | 1.020 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 9.551183e-02 | 1.020 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.551183e-02 | 1.020 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.114718e-01 | 0.953 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.114718e-01 | 0.953 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.068435e-01 | 0.971 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 9.994838e-02 | 1.000 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.193182e-01 | 0.923 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.111072e-01 | 0.954 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 9.202685e-02 | 1.036 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.299604e-02 | 1.032 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 9.276384e-02 | 1.033 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.214342e-01 | 0.916 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.185928e-01 | 0.926 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.149839e-01 | 0.939 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.068435e-01 | 0.971 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.342506e-02 | 1.030 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.176611e-01 | 0.929 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 9.275405e-02 | 1.033 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 9.637726e-02 | 1.016 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 1.064689e-01 | 0.973 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 9.514062e-02 | 1.022 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 1.114718e-01 | 0.953 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.008798e-01 | 0.996 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.068435e-01 | 0.971 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 9.342506e-02 | 1.030 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.175077e-01 | 0.930 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.060079e-01 | 0.975 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 1.149894e-01 | 0.939 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.187442e-02 | 1.037 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.140512e-01 | 0.943 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 9.441623e-02 | 1.025 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.060079e-01 | 0.975 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.068435e-01 | 0.971 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.060001e-01 | 0.975 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.068435e-01 | 0.971 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.141150e-01 | 0.943 | 0 | 0 |
| Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | R-HSA-180897 | 1.107744e-01 | 0.956 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 1.149839e-01 | 0.939 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.149894e-01 | 0.939 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 1.149894e-01 | 0.939 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.111072e-01 | 0.954 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.182735e-01 | 0.927 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.089440e-01 | 0.963 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.008798e-01 | 0.996 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.193182e-01 | 0.923 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.214342e-01 | 0.916 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 9.275405e-02 | 1.033 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.485617e-02 | 1.023 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.068435e-01 | 0.971 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.149839e-01 | 0.939 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 9.637726e-02 | 1.016 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.229414e-01 | 0.910 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.229414e-01 | 0.910 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.245126e-01 | 0.905 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.245126e-01 | 0.905 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.252091e-01 | 0.902 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.268720e-01 | 0.897 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.268720e-01 | 0.897 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.268908e-01 | 0.897 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.280540e-01 | 0.893 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.281017e-01 | 0.892 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.281017e-01 | 0.892 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 1.286938e-01 | 0.890 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.286938e-01 | 0.890 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.286938e-01 | 0.890 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.317950e-01 | 0.880 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.319177e-01 | 0.880 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.319177e-01 | 0.880 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.319177e-01 | 0.880 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.325477e-01 | 0.878 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.325477e-01 | 0.878 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.325477e-01 | 0.878 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.325477e-01 | 0.878 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.351706e-01 | 0.869 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.351706e-01 | 0.869 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.351706e-01 | 0.869 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.351706e-01 | 0.869 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.351706e-01 | 0.869 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 1.351706e-01 | 0.869 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.354372e-01 | 0.868 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.354372e-01 | 0.868 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.354372e-01 | 0.868 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.354671e-01 | 0.868 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.358664e-01 | 0.867 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.367101e-01 | 0.864 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 1.367101e-01 | 0.864 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.374144e-01 | 0.862 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 1.374144e-01 | 0.862 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.374144e-01 | 0.862 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.382795e-01 | 0.859 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.382795e-01 | 0.859 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 1.384477e-01 | 0.859 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.384477e-01 | 0.859 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.392959e-01 | 0.856 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.392959e-01 | 0.856 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.392959e-01 | 0.856 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.392959e-01 | 0.856 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.392959e-01 | 0.856 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.392959e-01 | 0.856 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.392959e-01 | 0.856 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.430020e-01 | 0.845 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.430020e-01 | 0.845 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.430020e-01 | 0.845 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.430020e-01 | 0.845 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.437816e-01 | 0.842 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.452147e-01 | 0.838 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 1.465091e-01 | 0.834 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.465091e-01 | 0.834 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.471099e-01 | 0.832 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.474572e-01 | 0.831 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.476114e-01 | 0.831 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.479279e-01 | 0.830 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.583381e-01 | 0.800 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 2.088311e-01 | 0.680 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.088311e-01 | 0.680 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.088311e-01 | 0.680 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.088311e-01 | 0.680 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.700078e-01 | 0.770 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.700078e-01 | 0.770 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 1.700078e-01 | 0.770 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.700078e-01 | 0.770 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.654501e-01 | 0.781 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.654501e-01 | 0.781 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 1.567986e-01 | 0.805 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 1.567986e-01 | 0.805 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.567986e-01 | 0.805 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.931863e-01 | 0.714 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.797344e-01 | 0.745 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.797344e-01 | 0.745 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.222347e-01 | 0.653 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 2.222347e-01 | 0.653 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 2.222347e-01 | 0.653 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.222347e-01 | 0.653 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.666396e-01 | 0.778 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.666396e-01 | 0.778 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 1.666396e-01 | 0.778 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.543608e-01 | 0.811 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 1.871911e-01 | 0.728 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.871911e-01 | 0.728 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.871911e-01 | 0.728 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.587159e-01 | 0.799 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.086644e-01 | 0.681 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 1.909161e-01 | 0.719 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.909161e-01 | 0.719 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.102860e-01 | 0.677 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.062564e-01 | 0.686 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.962690e-01 | 0.707 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.577748e-01 | 0.802 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.696480e-01 | 0.770 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.576151e-01 | 0.802 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.041375e-01 | 0.690 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.083420e-01 | 0.681 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.901171e-01 | 0.721 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.859193e-01 | 0.731 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.916192e-01 | 0.718 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.214417e-01 | 0.655 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.088311e-01 | 0.680 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.871911e-01 | 0.728 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.102860e-01 | 0.677 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.195928e-01 | 0.658 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.175513e-01 | 0.662 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.088311e-01 | 0.680 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.053246e-01 | 0.688 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.931863e-01 | 0.714 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.485767e-01 | 0.828 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.722163e-01 | 0.764 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.925418e-01 | 0.715 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.086644e-01 | 0.681 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.827331e-01 | 0.738 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.722163e-01 | 0.764 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.752008e-01 | 0.756 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.983363e-01 | 0.703 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.797344e-01 | 0.745 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.625878e-01 | 0.789 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.170018e-01 | 0.664 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.499054e-01 | 0.824 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 1.924085e-01 | 0.716 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.765117e-01 | 0.753 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.522476e-01 | 0.817 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.834495e-01 | 0.736 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.583381e-01 | 0.800 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 2.088311e-01 | 0.680 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.585111e-01 | 0.800 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.871911e-01 | 0.728 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.753208e-01 | 0.756 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.053246e-01 | 0.688 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.621786e-01 | 0.790 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.214417e-01 | 0.655 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.611747e-01 | 0.793 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.764150e-01 | 0.753 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.766952e-01 | 0.753 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.583381e-01 | 0.800 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.583381e-01 | 0.800 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.654501e-01 | 0.781 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.654501e-01 | 0.781 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.222347e-01 | 0.653 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.871911e-01 | 0.728 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.103889e-01 | 0.677 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.901171e-01 | 0.721 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.752008e-01 | 0.756 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.925418e-01 | 0.715 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 1.931863e-01 | 0.714 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.070777e-01 | 0.684 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 2.222347e-01 | 0.653 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.797344e-01 | 0.745 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.874172e-01 | 0.727 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.259368e-01 | 0.646 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.267973e-01 | 0.644 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 2.268071e-01 | 0.644 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.275120e-01 | 0.643 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.287759e-01 | 0.641 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.287759e-01 | 0.641 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.289138e-01 | 0.640 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.289138e-01 | 0.640 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.289138e-01 | 0.640 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.309527e-01 | 0.636 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.325546e-01 | 0.633 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.328039e-01 | 0.633 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.371916e-01 | 0.625 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.464397e-01 | 0.608 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.464397e-01 | 0.608 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.464397e-01 | 0.608 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.464397e-01 | 0.608 | 0 | 0 |
| Defective F8 binding to von Willebrand factor | R-HSA-9672393 | 2.464397e-01 | 0.608 | 0 | 0 |
| TGFBR2 MSI Frameshift Mutants in Cancer | R-HSA-3642279 | 2.464397e-01 | 0.608 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.464397e-01 | 0.608 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.464397e-01 | 0.608 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.464397e-01 | 0.608 | 0 | 0 |
| TWIK-related spinal cord K+ channel (TRESK) | R-HSA-1299344 | 2.464397e-01 | 0.608 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.464397e-01 | 0.608 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.464397e-01 | 0.608 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.464397e-01 | 0.608 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.464397e-01 | 0.608 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.458591e-01 | 0.461 | 0 | 0 |
| Signaling by FGFR3 fusions in cancer | R-HSA-8853334 | 3.458591e-01 | 0.461 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.458591e-01 | 0.461 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.458591e-01 | 0.461 | 0 | 0 |
| t(4;14) translocations of FGFR3 | R-HSA-2033515 | 3.458591e-01 | 0.461 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.458591e-01 | 0.461 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.458591e-01 | 0.461 | 0 | 0 |
| Defective APRT disrupts adenine salvage | R-HSA-9734195 | 3.458591e-01 | 0.461 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.458591e-01 | 0.461 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 3.458591e-01 | 0.461 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.458591e-01 | 0.461 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.458591e-01 | 0.461 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.458591e-01 | 0.461 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 3.458591e-01 | 0.461 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.458591e-01 | 0.461 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 3.458591e-01 | 0.461 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.458591e-01 | 0.461 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.606537e-01 | 0.584 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.606537e-01 | 0.584 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.606537e-01 | 0.584 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.606537e-01 | 0.584 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.606537e-01 | 0.584 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.606537e-01 | 0.584 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.606537e-01 | 0.584 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 2.606537e-01 | 0.584 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.421062e-01 | 0.616 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.421062e-01 | 0.616 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.421062e-01 | 0.616 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.421062e-01 | 0.616 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 2.421062e-01 | 0.616 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.125769e-01 | 0.505 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 3.125769e-01 | 0.505 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.125769e-01 | 0.505 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.125769e-01 | 0.505 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.125769e-01 | 0.505 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 3.125769e-01 | 0.505 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 3.125769e-01 | 0.505 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.125769e-01 | 0.505 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 3.125769e-01 | 0.505 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.321668e-01 | 0.364 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 4.321668e-01 | 0.364 | 0 | 0 |
| Defective F8 cleavage by thrombin | R-HSA-9672391 | 4.321668e-01 | 0.364 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.321668e-01 | 0.364 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.321668e-01 | 0.364 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 4.321668e-01 | 0.364 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.321668e-01 | 0.364 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 4.321668e-01 | 0.364 | 0 | 0 |
| Essential pentosuria | R-HSA-5662853 | 4.321668e-01 | 0.364 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.636728e-01 | 0.439 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.636728e-01 | 0.439 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 3.180435e-01 | 0.498 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.831842e-01 | 0.548 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.831842e-01 | 0.548 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.831842e-01 | 0.548 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.831842e-01 | 0.548 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.831842e-01 | 0.548 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.539448e-01 | 0.595 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.814163e-01 | 0.551 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.814163e-01 | 0.551 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.145611e-01 | 0.502 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.563115e-01 | 0.448 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 3.563115e-01 | 0.448 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.563115e-01 | 0.448 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.563115e-01 | 0.448 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.132563e-01 | 0.384 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.132563e-01 | 0.384 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 4.132563e-01 | 0.384 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 4.132563e-01 | 0.384 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.132563e-01 | 0.384 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.132563e-01 | 0.384 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 4.132563e-01 | 0.384 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.132563e-01 | 0.384 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 2.513442e-01 | 0.600 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.775267e-01 | 0.557 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.775267e-01 | 0.557 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.085008e-01 | 0.511 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.462111e-01 | 0.461 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.015837e-01 | 0.521 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.015837e-01 | 0.521 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.942757e-01 | 0.404 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 3.942757e-01 | 0.404 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.673483e-01 | 0.573 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 2.394543e-01 | 0.621 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.260017e-01 | 0.487 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.779089e-01 | 0.423 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.779089e-01 | 0.423 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.608371e-01 | 0.336 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 4.608371e-01 | 0.336 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.608371e-01 | 0.336 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.608371e-01 | 0.336 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 2.560372e-01 | 0.592 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.754768e-01 | 0.425 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.615739e-01 | 0.442 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.842895e-01 | 0.415 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.842895e-01 | 0.415 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.003214e-01 | 0.398 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.406454e-01 | 0.356 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 4.406454e-01 | 0.356 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.680997e-01 | 0.330 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 4.680997e-01 | 0.330 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.680997e-01 | 0.330 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.680997e-01 | 0.330 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 4.680997e-01 | 0.330 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.680997e-01 | 0.330 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.637875e-01 | 0.439 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.070387e-01 | 0.390 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 4.070387e-01 | 0.390 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 4.713352e-01 | 0.327 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.424863e-01 | 0.465 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.424863e-01 | 0.465 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.364502e-01 | 0.473 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.944263e-01 | 0.404 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.553780e-01 | 0.449 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.947665e-01 | 0.404 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.947665e-01 | 0.404 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.569459e-01 | 0.340 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 2.380403e-01 | 0.623 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.743882e-01 | 0.324 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.743882e-01 | 0.324 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 2.618447e-01 | 0.582 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.358569e-01 | 0.474 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 4.047375e-01 | 0.393 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 4.611311e-01 | 0.336 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.798358e-01 | 0.553 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.316251e-01 | 0.365 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.548325e-01 | 0.594 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.394523e-01 | 0.469 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.394523e-01 | 0.469 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.586304e-01 | 0.339 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.764638e-01 | 0.424 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.047375e-01 | 0.393 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.734871e-01 | 0.428 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.638175e-01 | 0.579 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.394523e-01 | 0.469 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.775267e-01 | 0.557 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.664390e-01 | 0.436 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 2.873023e-01 | 0.542 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.484741e-01 | 0.605 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.346491e-01 | 0.362 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.798358e-01 | 0.553 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.798358e-01 | 0.553 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 2.673483e-01 | 0.573 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.125769e-01 | 0.505 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.798358e-01 | 0.553 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 3.942757e-01 | 0.404 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.779089e-01 | 0.423 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.165619e-01 | 0.500 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.490411e-01 | 0.457 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.680997e-01 | 0.330 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.753188e-01 | 0.560 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.490411e-01 | 0.457 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.001750e-01 | 0.523 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.359259e-01 | 0.474 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 4.608371e-01 | 0.336 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 2.539448e-01 | 0.595 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.636728e-01 | 0.439 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.563115e-01 | 0.448 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.608371e-01 | 0.336 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.735155e-01 | 0.563 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.147956e-01 | 0.502 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.622899e-01 | 0.581 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.993919e-01 | 0.399 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 3.779089e-01 | 0.423 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.636728e-01 | 0.439 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.775267e-01 | 0.557 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 3.942757e-01 | 0.404 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.673483e-01 | 0.573 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.260017e-01 | 0.487 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 3.734871e-01 | 0.428 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.542819e-01 | 0.343 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.542819e-01 | 0.343 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 3.965475e-01 | 0.402 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.775267e-01 | 0.557 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.687796e-01 | 0.329 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.332901e-01 | 0.363 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.762701e-01 | 0.425 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.277323e-01 | 0.484 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 2.421062e-01 | 0.616 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 2.421062e-01 | 0.616 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.539448e-01 | 0.595 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.779089e-01 | 0.423 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.693817e-01 | 0.433 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.693817e-01 | 0.433 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.693817e-01 | 0.433 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.693817e-01 | 0.433 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 4.332901e-01 | 0.363 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.821310e-01 | 0.550 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 3.462111e-01 | 0.461 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.754768e-01 | 0.425 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.823963e-01 | 0.549 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.974401e-01 | 0.527 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.043129e-01 | 0.517 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.624405e-01 | 0.581 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 3.791486e-01 | 0.421 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.462646e-01 | 0.461 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 2.775267e-01 | 0.557 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.437770e-01 | 0.613 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.910003e-01 | 0.408 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.523231e-01 | 0.598 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.636728e-01 | 0.439 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.145611e-01 | 0.502 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.132563e-01 | 0.384 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.094487e-01 | 0.388 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.797556e-01 | 0.553 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.741187e-01 | 0.324 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.741187e-01 | 0.324 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.427907e-01 | 0.615 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.542819e-01 | 0.343 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.656617e-01 | 0.437 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.437770e-01 | 0.613 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.991294e-01 | 0.524 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.831842e-01 | 0.548 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.462111e-01 | 0.461 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.730858e-01 | 0.325 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 4.406454e-01 | 0.356 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.059704e-01 | 0.392 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.464397e-01 | 0.608 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.464397e-01 | 0.608 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.458591e-01 | 0.461 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.458591e-01 | 0.461 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.125769e-01 | 0.505 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.321668e-01 | 0.364 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.321668e-01 | 0.364 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.321668e-01 | 0.364 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.321668e-01 | 0.364 | 0 | 0 |
| Influenza Virus Induced Apoptosis | R-HSA-168277 | 4.321668e-01 | 0.364 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.145611e-01 | 0.502 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.145611e-01 | 0.502 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 3.145611e-01 | 0.502 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 4.132563e-01 | 0.384 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.608371e-01 | 0.336 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 4.608371e-01 | 0.336 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.803131e-01 | 0.552 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.316251e-01 | 0.365 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.316251e-01 | 0.365 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.490411e-01 | 0.457 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.490411e-01 | 0.457 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.375906e-01 | 0.472 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.079936e-01 | 0.511 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 4.680997e-01 | 0.330 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.146073e-01 | 0.502 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.680997e-01 | 0.330 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.693817e-01 | 0.433 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.346491e-01 | 0.362 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.831842e-01 | 0.548 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 3.180435e-01 | 0.498 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.180435e-01 | 0.498 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.406454e-01 | 0.356 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 3.506689e-01 | 0.455 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.919211e-01 | 0.535 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.417474e-01 | 0.355 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.421062e-01 | 0.616 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.814163e-01 | 0.551 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.462646e-01 | 0.461 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.635378e-01 | 0.439 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.591319e-01 | 0.445 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.359259e-01 | 0.474 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.380511e-01 | 0.623 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.673483e-01 | 0.573 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.085008e-01 | 0.511 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.375906e-01 | 0.472 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 3.458591e-01 | 0.461 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 2.606537e-01 | 0.584 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.125769e-01 | 0.505 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.911907e-01 | 0.408 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.406454e-01 | 0.356 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.497318e-01 | 0.347 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.741187e-01 | 0.324 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.834096e-01 | 0.548 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 4.336300e-01 | 0.363 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.947665e-01 | 0.404 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.636728e-01 | 0.439 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 2.548325e-01 | 0.594 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 4.680997e-01 | 0.330 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.741187e-01 | 0.324 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.798358e-01 | 0.553 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.606537e-01 | 0.584 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.321668e-01 | 0.364 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.132563e-01 | 0.384 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 4.132563e-01 | 0.384 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.132563e-01 | 0.384 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.437770e-01 | 0.613 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.608371e-01 | 0.336 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.690077e-01 | 0.570 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 4.680997e-01 | 0.330 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.606537e-01 | 0.584 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.125769e-01 | 0.505 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.180435e-01 | 0.498 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.132563e-01 | 0.384 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.608371e-01 | 0.336 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.571276e-01 | 0.447 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 3.965475e-01 | 0.402 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.760372e-01 | 0.559 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 3.635378e-01 | 0.439 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 4.094487e-01 | 0.388 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.753502e-01 | 0.323 | 0 | 0 |
| Immune System | R-HSA-168256 | 4.889866e-01 | 0.311 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.938357e-01 | 0.306 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.947679e-01 | 0.306 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.947679e-01 | 0.306 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.957869e-01 | 0.305 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 4.981856e-01 | 0.303 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.982433e-01 | 0.303 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.990460e-01 | 0.302 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.994601e-01 | 0.301 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.996470e-01 | 0.301 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.996470e-01 | 0.301 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.996470e-01 | 0.301 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 5.013754e-01 | 0.300 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.013754e-01 | 0.300 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 5.026887e-01 | 0.299 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.034875e-01 | 0.298 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.034875e-01 | 0.298 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.034875e-01 | 0.298 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.034875e-01 | 0.298 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 5.034875e-01 | 0.298 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.034875e-01 | 0.298 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.034875e-01 | 0.298 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 5.034875e-01 | 0.298 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.034875e-01 | 0.298 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 5.060809e-01 | 0.296 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 5.060809e-01 | 0.296 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 5.060809e-01 | 0.296 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 5.060809e-01 | 0.296 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 5.060809e-01 | 0.296 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 5.060809e-01 | 0.296 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.060809e-01 | 0.296 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 5.060809e-01 | 0.296 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 5.070914e-01 | 0.295 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.070914e-01 | 0.295 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.070914e-01 | 0.295 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.070914e-01 | 0.295 | 0 | 0 |
| Defective CYP1B1 causes Glaucoma | R-HSA-5579000 | 5.070914e-01 | 0.295 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 5.070914e-01 | 0.295 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.070914e-01 | 0.295 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.070914e-01 | 0.295 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.070914e-01 | 0.295 | 0 | 0 |
| Defective CYP7B1 causes SPG5A and CBAS3 | R-HSA-5579013 | 5.070914e-01 | 0.295 | 0 | 0 |
| Defective MAOA causes BRUNS | R-HSA-5579012 | 5.070914e-01 | 0.295 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 5.070914e-01 | 0.295 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.070914e-01 | 0.295 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 5.070914e-01 | 0.295 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 5.070914e-01 | 0.295 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.070914e-01 | 0.295 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.103249e-01 | 0.292 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.104232e-01 | 0.292 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.115099e-01 | 0.291 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.120489e-01 | 0.291 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.120489e-01 | 0.291 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.139870e-01 | 0.289 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.180006e-01 | 0.286 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.180006e-01 | 0.286 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.188460e-01 | 0.285 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.190461e-01 | 0.285 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.200175e-01 | 0.284 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.218604e-01 | 0.282 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.218604e-01 | 0.282 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.225643e-01 | 0.282 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.229881e-01 | 0.282 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.256768e-01 | 0.279 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 5.256768e-01 | 0.279 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.256768e-01 | 0.279 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.263743e-01 | 0.279 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.302742e-01 | 0.275 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 5.306440e-01 | 0.275 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 5.306440e-01 | 0.275 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 5.306440e-01 | 0.275 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.362254e-01 | 0.271 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 5.363260e-01 | 0.271 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.373039e-01 | 0.270 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.376199e-01 | 0.270 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.376199e-01 | 0.270 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.379631e-01 | 0.269 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.388318e-01 | 0.269 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.435850e-01 | 0.265 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.450783e-01 | 0.264 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.478461e-01 | 0.261 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 5.487759e-01 | 0.261 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.487759e-01 | 0.261 | 0 | 0 |
| Metabolism of serotonin | R-HSA-380612 | 5.487759e-01 | 0.261 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.487759e-01 | 0.261 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 5.487759e-01 | 0.261 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 5.487759e-01 | 0.261 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.487759e-01 | 0.261 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 5.487759e-01 | 0.261 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.487759e-01 | 0.261 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 5.487759e-01 | 0.261 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 5.487759e-01 | 0.261 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 5.487759e-01 | 0.261 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.510950e-01 | 0.259 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.510950e-01 | 0.259 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.510950e-01 | 0.259 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.516783e-01 | 0.258 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.516783e-01 | 0.258 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.516783e-01 | 0.258 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.543219e-01 | 0.256 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.561237e-01 | 0.255 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.561237e-01 | 0.255 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.563806e-01 | 0.255 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 5.590388e-01 | 0.253 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 5.590388e-01 | 0.253 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.590388e-01 | 0.253 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 5.590388e-01 | 0.253 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.590388e-01 | 0.253 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.590388e-01 | 0.253 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 5.590388e-01 | 0.253 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 5.590388e-01 | 0.253 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.629853e-01 | 0.250 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.657606e-01 | 0.247 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.661473e-01 | 0.247 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.677821e-01 | 0.246 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.703683e-01 | 0.244 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.703683e-01 | 0.244 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.703683e-01 | 0.244 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.703683e-01 | 0.244 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 5.703683e-01 | 0.244 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.721335e-01 | 0.243 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.721335e-01 | 0.243 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.721335e-01 | 0.243 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.721335e-01 | 0.243 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 5.721335e-01 | 0.243 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.721335e-01 | 0.243 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 5.721335e-01 | 0.243 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.721335e-01 | 0.243 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 5.721335e-01 | 0.243 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 5.721335e-01 | 0.243 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 5.721335e-01 | 0.243 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 5.721335e-01 | 0.243 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.721335e-01 | 0.243 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.721335e-01 | 0.243 | 0 | 0 |
| Interleukin-38 signaling | R-HSA-9007892 | 5.721335e-01 | 0.243 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.758322e-01 | 0.240 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.758322e-01 | 0.240 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.818526e-01 | 0.235 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.847091e-01 | 0.233 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 5.864767e-01 | 0.232 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.864767e-01 | 0.232 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.864767e-01 | 0.232 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 5.864767e-01 | 0.232 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.880881e-01 | 0.231 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.881507e-01 | 0.231 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.888070e-01 | 0.230 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 5.888070e-01 | 0.230 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.888070e-01 | 0.230 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 5.888070e-01 | 0.230 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.888070e-01 | 0.230 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 5.888070e-01 | 0.230 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.906665e-01 | 0.229 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.906665e-01 | 0.229 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.907784e-01 | 0.229 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 5.998303e-01 | 0.222 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.016391e-01 | 0.221 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.016391e-01 | 0.221 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.019266e-01 | 0.220 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.058568e-01 | 0.218 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.058568e-01 | 0.218 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 6.058568e-01 | 0.218 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.093136e-01 | 0.215 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.093136e-01 | 0.215 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.128917e-01 | 0.213 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.128917e-01 | 0.213 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.128917e-01 | 0.213 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 6.128917e-01 | 0.213 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.128917e-01 | 0.213 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.131903e-01 | 0.212 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.140113e-01 | 0.212 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.140113e-01 | 0.212 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.141889e-01 | 0.212 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.218561e-01 | 0.206 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.218561e-01 | 0.206 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.230413e-01 | 0.205 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 6.261339e-01 | 0.203 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 6.261339e-01 | 0.203 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.261339e-01 | 0.203 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.285963e-01 | 0.202 | 0 | 0 |
| Defective CYP17A1 causes AH5 | R-HSA-5579028 | 6.285963e-01 | 0.202 | 0 | 0 |
| IRS activation | R-HSA-74713 | 6.285963e-01 | 0.202 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.285963e-01 | 0.202 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.285963e-01 | 0.202 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.285963e-01 | 0.202 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.285963e-01 | 0.202 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 6.285963e-01 | 0.202 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.285963e-01 | 0.202 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.285963e-01 | 0.202 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 6.285963e-01 | 0.202 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.285963e-01 | 0.202 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.285963e-01 | 0.202 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 6.285963e-01 | 0.202 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 6.285963e-01 | 0.202 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.285963e-01 | 0.202 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 6.285963e-01 | 0.202 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.313695e-01 | 0.200 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.313695e-01 | 0.200 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.313695e-01 | 0.200 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 6.313695e-01 | 0.200 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.369556e-01 | 0.196 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.382342e-01 | 0.195 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.382342e-01 | 0.195 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.382342e-01 | 0.195 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.382342e-01 | 0.195 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 6.400873e-01 | 0.194 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 6.453414e-01 | 0.190 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.454269e-01 | 0.190 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.454269e-01 | 0.190 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.490046e-01 | 0.188 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.525553e-01 | 0.185 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.525553e-01 | 0.185 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.525553e-01 | 0.185 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.564447e-01 | 0.183 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.565717e-01 | 0.183 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 6.565717e-01 | 0.183 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 6.594855e-01 | 0.181 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.594855e-01 | 0.181 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.595235e-01 | 0.181 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.595235e-01 | 0.181 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.595235e-01 | 0.181 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 6.595235e-01 | 0.181 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.595235e-01 | 0.181 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 6.607732e-01 | 0.180 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 6.607732e-01 | 0.180 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 6.607732e-01 | 0.180 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.607732e-01 | 0.180 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 6.607732e-01 | 0.180 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.607732e-01 | 0.180 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 6.607732e-01 | 0.180 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.607732e-01 | 0.180 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 6.607732e-01 | 0.180 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.607732e-01 | 0.180 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.607732e-01 | 0.180 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.607732e-01 | 0.180 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.607732e-01 | 0.180 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 6.624692e-01 | 0.179 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.624692e-01 | 0.179 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 6.624692e-01 | 0.179 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 6.661742e-01 | 0.176 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 6.661898e-01 | 0.176 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.669582e-01 | 0.176 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.669582e-01 | 0.176 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.681495e-01 | 0.175 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.720721e-01 | 0.173 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 6.774235e-01 | 0.169 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.776108e-01 | 0.169 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.776108e-01 | 0.169 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.776108e-01 | 0.169 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.776108e-01 | 0.169 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.776108e-01 | 0.169 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.776108e-01 | 0.169 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.776108e-01 | 0.169 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.776108e-01 | 0.169 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.776108e-01 | 0.169 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.776108e-01 | 0.169 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.776108e-01 | 0.169 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.776108e-01 | 0.169 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.776108e-01 | 0.169 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.776108e-01 | 0.169 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.776108e-01 | 0.169 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.776108e-01 | 0.169 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 6.776108e-01 | 0.169 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.776108e-01 | 0.169 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.776108e-01 | 0.169 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 6.776108e-01 | 0.169 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 6.831650e-01 | 0.165 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.847728e-01 | 0.164 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.855748e-01 | 0.164 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 6.855748e-01 | 0.164 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.855748e-01 | 0.164 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.855748e-01 | 0.164 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.860880e-01 | 0.164 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.860880e-01 | 0.164 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.860880e-01 | 0.164 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.876145e-01 | 0.163 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.876145e-01 | 0.163 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.881988e-01 | 0.162 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.908738e-01 | 0.161 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.908738e-01 | 0.161 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.908738e-01 | 0.161 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 6.927839e-01 | 0.159 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 6.927839e-01 | 0.159 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 6.927839e-01 | 0.159 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 6.927839e-01 | 0.159 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.927839e-01 | 0.159 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 6.927839e-01 | 0.159 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.927839e-01 | 0.159 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.927839e-01 | 0.159 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.927839e-01 | 0.159 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.927839e-01 | 0.159 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.947555e-01 | 0.158 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.947789e-01 | 0.158 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.960613e-01 | 0.157 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.075410e-01 | 0.150 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.075410e-01 | 0.150 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.077369e-01 | 0.150 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.110691e-01 | 0.148 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 7.110691e-01 | 0.148 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.164448e-01 | 0.145 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 7.201593e-01 | 0.143 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 7.201593e-01 | 0.143 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 7.201593e-01 | 0.143 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 7.201593e-01 | 0.143 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 7.201593e-01 | 0.143 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 7.201593e-01 | 0.143 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 7.201593e-01 | 0.143 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 7.201593e-01 | 0.143 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 7.201593e-01 | 0.143 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 7.201593e-01 | 0.143 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 7.201593e-01 | 0.143 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.208907e-01 | 0.142 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 7.222566e-01 | 0.141 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.222566e-01 | 0.141 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 7.222566e-01 | 0.141 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 7.222566e-01 | 0.141 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.222566e-01 | 0.141 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.222566e-01 | 0.141 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.222566e-01 | 0.141 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.226701e-01 | 0.141 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 7.262576e-01 | 0.139 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 7.283680e-01 | 0.138 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.283680e-01 | 0.138 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.283680e-01 | 0.138 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.293606e-01 | 0.137 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.328131e-01 | 0.135 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.328131e-01 | 0.135 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.344885e-01 | 0.134 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.428880e-01 | 0.129 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 7.430225e-01 | 0.129 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.430225e-01 | 0.129 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 7.442388e-01 | 0.128 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 7.442388e-01 | 0.128 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.479150e-01 | 0.126 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 7.480650e-01 | 0.126 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.480650e-01 | 0.126 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.493035e-01 | 0.125 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.493035e-01 | 0.125 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.493035e-01 | 0.125 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.493035e-01 | 0.125 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 7.493035e-01 | 0.125 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.529195e-01 | 0.123 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.556544e-01 | 0.122 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 7.563814e-01 | 0.121 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.563814e-01 | 0.121 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.563814e-01 | 0.121 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 7.570945e-01 | 0.121 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 7.570945e-01 | 0.121 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.570945e-01 | 0.121 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 7.570945e-01 | 0.121 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.570945e-01 | 0.121 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.570945e-01 | 0.121 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.570945e-01 | 0.121 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 7.570945e-01 | 0.121 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.570945e-01 | 0.121 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.570945e-01 | 0.121 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 7.570945e-01 | 0.121 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 7.570945e-01 | 0.121 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.570945e-01 | 0.121 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 7.570945e-01 | 0.121 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.575406e-01 | 0.121 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.578552e-01 | 0.120 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.578552e-01 | 0.120 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.578552e-01 | 0.120 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 7.580513e-01 | 0.120 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.580513e-01 | 0.120 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.580988e-01 | 0.120 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.584790e-01 | 0.120 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.584790e-01 | 0.120 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.587526e-01 | 0.120 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.589862e-01 | 0.120 | 0 | 0 |
| Depurination | R-HSA-73927 | 7.613326e-01 | 0.118 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.613326e-01 | 0.118 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.613326e-01 | 0.118 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.624335e-01 | 0.118 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 7.663922e-01 | 0.116 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.665691e-01 | 0.115 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.714543e-01 | 0.113 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.725136e-01 | 0.112 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.738857e-01 | 0.111 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.738857e-01 | 0.111 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.740515e-01 | 0.111 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.740515e-01 | 0.111 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.740515e-01 | 0.111 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 7.740515e-01 | 0.111 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.740515e-01 | 0.111 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.740515e-01 | 0.111 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.740515e-01 | 0.111 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 7.740515e-01 | 0.111 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 7.753408e-01 | 0.111 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.767928e-01 | 0.110 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.767928e-01 | 0.110 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.775497e-01 | 0.109 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 7.775497e-01 | 0.109 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.775497e-01 | 0.109 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 7.839015e-01 | 0.106 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.839015e-01 | 0.106 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.839015e-01 | 0.106 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.839015e-01 | 0.106 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.841426e-01 | 0.106 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.841426e-01 | 0.106 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.856440e-01 | 0.105 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.891565e-01 | 0.103 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.891565e-01 | 0.103 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.891565e-01 | 0.103 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.891565e-01 | 0.103 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.891565e-01 | 0.103 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.891565e-01 | 0.103 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.891565e-01 | 0.103 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.891565e-01 | 0.103 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.891565e-01 | 0.103 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.891565e-01 | 0.103 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 7.891565e-01 | 0.103 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.891565e-01 | 0.103 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.891565e-01 | 0.103 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.891565e-01 | 0.103 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.891565e-01 | 0.103 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.891565e-01 | 0.103 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.891565e-01 | 0.103 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 7.891565e-01 | 0.103 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.891565e-01 | 0.103 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.925933e-01 | 0.101 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.929054e-01 | 0.101 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.929054e-01 | 0.101 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.929054e-01 | 0.101 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.929054e-01 | 0.101 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.929054e-01 | 0.101 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.953611e-01 | 0.099 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.957760e-01 | 0.099 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.966360e-01 | 0.099 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.966360e-01 | 0.099 | 0 | 0 |
| Formation of xylulose-5-phosphate | R-HSA-5661270 | 7.966360e-01 | 0.099 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 7.966360e-01 | 0.099 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.986123e-01 | 0.098 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.059493e-01 | 0.094 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 8.068468e-01 | 0.093 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.074183e-01 | 0.093 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.074183e-01 | 0.093 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.074183e-01 | 0.093 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.133902e-01 | 0.090 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 8.145047e-01 | 0.089 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 8.145047e-01 | 0.089 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.166438e-01 | 0.088 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 8.169882e-01 | 0.088 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 8.169882e-01 | 0.088 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 8.169882e-01 | 0.088 | 0 | 0 |
| Enzymatic degradation of Dopamine by monoamine oxidase | R-HSA-379398 | 8.169882e-01 | 0.088 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 8.169882e-01 | 0.088 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 8.169882e-01 | 0.088 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 8.169882e-01 | 0.088 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 8.169882e-01 | 0.088 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.169882e-01 | 0.088 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.169882e-01 | 0.088 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.171970e-01 | 0.088 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.171970e-01 | 0.088 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 8.171970e-01 | 0.088 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 8.176690e-01 | 0.087 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.211102e-01 | 0.086 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.211102e-01 | 0.086 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.211102e-01 | 0.086 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.211102e-01 | 0.086 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.211102e-01 | 0.086 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.250245e-01 | 0.084 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.264049e-01 | 0.083 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.279861e-01 | 0.082 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.279861e-01 | 0.082 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.283231e-01 | 0.082 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.296988e-01 | 0.081 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.303920e-01 | 0.081 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.303920e-01 | 0.081 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.303920e-01 | 0.081 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.340056e-01 | 0.079 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.340056e-01 | 0.079 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.340056e-01 | 0.079 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.358751e-01 | 0.078 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.358751e-01 | 0.078 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.358751e-01 | 0.078 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 8.358751e-01 | 0.078 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.358751e-01 | 0.078 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 8.358751e-01 | 0.078 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.378468e-01 | 0.077 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.381771e-01 | 0.077 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.389681e-01 | 0.076 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 8.411475e-01 | 0.075 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.411475e-01 | 0.075 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.411475e-01 | 0.075 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.411475e-01 | 0.075 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.411475e-01 | 0.075 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.411475e-01 | 0.075 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.411475e-01 | 0.075 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 8.411475e-01 | 0.075 | 0 | 0 |
| Enzymatic degradation of dopamine by COMT | R-HSA-379397 | 8.411475e-01 | 0.075 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.411475e-01 | 0.075 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.445484e-01 | 0.073 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.447681e-01 | 0.073 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.447681e-01 | 0.073 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.447681e-01 | 0.073 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.447681e-01 | 0.073 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.447681e-01 | 0.073 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.461309e-01 | 0.073 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.461309e-01 | 0.073 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.499789e-01 | 0.071 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.499789e-01 | 0.071 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.528089e-01 | 0.069 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.528089e-01 | 0.069 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 8.528089e-01 | 0.069 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 8.528089e-01 | 0.069 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.562372e-01 | 0.067 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.564000e-01 | 0.067 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.575140e-01 | 0.067 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.583506e-01 | 0.066 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.586658e-01 | 0.066 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.586658e-01 | 0.066 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.586658e-01 | 0.066 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.586658e-01 | 0.066 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.586658e-01 | 0.066 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.596285e-01 | 0.066 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.599574e-01 | 0.066 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.603665e-01 | 0.065 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.621187e-01 | 0.064 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 8.621187e-01 | 0.064 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.621187e-01 | 0.064 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.621187e-01 | 0.064 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.621187e-01 | 0.064 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.621187e-01 | 0.064 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.621187e-01 | 0.064 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.621187e-01 | 0.064 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.621187e-01 | 0.064 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.621187e-01 | 0.064 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.641648e-01 | 0.063 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.659590e-01 | 0.063 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.680786e-01 | 0.061 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.681335e-01 | 0.061 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.681335e-01 | 0.061 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 8.681335e-01 | 0.061 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.681335e-01 | 0.061 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.681335e-01 | 0.061 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.681335e-01 | 0.061 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.681335e-01 | 0.061 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.681843e-01 | 0.061 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.681843e-01 | 0.061 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.681843e-01 | 0.061 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.684164e-01 | 0.061 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.701525e-01 | 0.060 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.714599e-01 | 0.060 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.781716e-01 | 0.056 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.789307e-01 | 0.056 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.793596e-01 | 0.056 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.800454e-01 | 0.055 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 8.803224e-01 | 0.055 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 8.803224e-01 | 0.055 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.803224e-01 | 0.055 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.803224e-01 | 0.055 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 8.803224e-01 | 0.055 | 0 | 0 |
| Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB | R-HSA-141333 | 8.803224e-01 | 0.055 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 8.803224e-01 | 0.055 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.803224e-01 | 0.055 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.803224e-01 | 0.055 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.811706e-01 | 0.055 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.819785e-01 | 0.055 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.819785e-01 | 0.055 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.819785e-01 | 0.055 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.819785e-01 | 0.055 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.875067e-01 | 0.052 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.875067e-01 | 0.052 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.889993e-01 | 0.051 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.889993e-01 | 0.051 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.940074e-01 | 0.049 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.940074e-01 | 0.049 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 8.944673e-01 | 0.048 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 8.944673e-01 | 0.048 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.944673e-01 | 0.048 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.961237e-01 | 0.048 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.961237e-01 | 0.048 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.961237e-01 | 0.048 | 0 | 0 |
| Proline catabolism | R-HSA-70688 | 8.961237e-01 | 0.048 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.961237e-01 | 0.048 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.961237e-01 | 0.048 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.961237e-01 | 0.048 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.961237e-01 | 0.048 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.961237e-01 | 0.048 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.961237e-01 | 0.048 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.961237e-01 | 0.048 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.969440e-01 | 0.047 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.991759e-01 | 0.046 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 9.003512e-01 | 0.046 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.037396e-01 | 0.044 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.038923e-01 | 0.044 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.043904e-01 | 0.044 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.057167e-01 | 0.043 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.057167e-01 | 0.043 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.057167e-01 | 0.043 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.057167e-01 | 0.043 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.057167e-01 | 0.043 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 9.098395e-01 | 0.041 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 9.098395e-01 | 0.041 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 9.098395e-01 | 0.041 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 9.098395e-01 | 0.041 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 9.098395e-01 | 0.041 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 9.098395e-01 | 0.041 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 9.098395e-01 | 0.041 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 9.098395e-01 | 0.041 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 9.098395e-01 | 0.041 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 9.098395e-01 | 0.041 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 9.098395e-01 | 0.041 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.100780e-01 | 0.041 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.108641e-01 | 0.041 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.110861e-01 | 0.040 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.119056e-01 | 0.040 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.149311e-01 | 0.039 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.158362e-01 | 0.038 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.158362e-01 | 0.038 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.158362e-01 | 0.038 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.175267e-01 | 0.037 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.175267e-01 | 0.037 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.211983e-01 | 0.036 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.211983e-01 | 0.036 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.211983e-01 | 0.036 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 9.217450e-01 | 0.035 | 0 | 0 |
| Transport of fatty acids | R-HSA-804914 | 9.217450e-01 | 0.035 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 9.217450e-01 | 0.035 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 9.217450e-01 | 0.035 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.217450e-01 | 0.035 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.222885e-01 | 0.035 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.232745e-01 | 0.035 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.249280e-01 | 0.034 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.249280e-01 | 0.034 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.254695e-01 | 0.034 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.254695e-01 | 0.034 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.254695e-01 | 0.034 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.287374e-01 | 0.032 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.287374e-01 | 0.032 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.287374e-01 | 0.032 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.294433e-01 | 0.032 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.294450e-01 | 0.032 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.295576e-01 | 0.032 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.315292e-01 | 0.031 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.320789e-01 | 0.031 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 9.320789e-01 | 0.031 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.320789e-01 | 0.031 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.320789e-01 | 0.031 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 9.320789e-01 | 0.031 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.320789e-01 | 0.031 | 0 | 0 |
| Events associated with phagocytolytic activity of PMN cells | R-HSA-8941413 | 9.320789e-01 | 0.031 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 9.320789e-01 | 0.031 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 9.320789e-01 | 0.031 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 9.320789e-01 | 0.031 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.320789e-01 | 0.031 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.320789e-01 | 0.031 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.320789e-01 | 0.031 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.330869e-01 | 0.030 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.330869e-01 | 0.030 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.330869e-01 | 0.030 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.330869e-01 | 0.030 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.330869e-01 | 0.030 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.338202e-01 | 0.030 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.339821e-01 | 0.030 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.348010e-01 | 0.029 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.353108e-01 | 0.029 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.371447e-01 | 0.028 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 9.379107e-01 | 0.028 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.381764e-01 | 0.028 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.386566e-01 | 0.027 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.386566e-01 | 0.027 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.404008e-01 | 0.027 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.404008e-01 | 0.027 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.404008e-01 | 0.027 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.404008e-01 | 0.027 | 0 | 0 |
| Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | R-HSA-2142816 | 9.410488e-01 | 0.026 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.410488e-01 | 0.026 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.410488e-01 | 0.026 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.410488e-01 | 0.026 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.410488e-01 | 0.026 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.410488e-01 | 0.026 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 9.410488e-01 | 0.026 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.410488e-01 | 0.026 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.410488e-01 | 0.026 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.410488e-01 | 0.026 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 9.410488e-01 | 0.026 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.410488e-01 | 0.026 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.410498e-01 | 0.026 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.410498e-01 | 0.026 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.432443e-01 | 0.025 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.463207e-01 | 0.024 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.463207e-01 | 0.024 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.469505e-01 | 0.024 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.469505e-01 | 0.024 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.469505e-01 | 0.024 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.471506e-01 | 0.024 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.475489e-01 | 0.023 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.475489e-01 | 0.023 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.475489e-01 | 0.023 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.484580e-01 | 0.023 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.486622e-01 | 0.023 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.488345e-01 | 0.023 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.488345e-01 | 0.023 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.488345e-01 | 0.023 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 9.488345e-01 | 0.023 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.488345e-01 | 0.023 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.488345e-01 | 0.023 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.488345e-01 | 0.023 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.511566e-01 | 0.022 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.543485e-01 | 0.020 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.551975e-01 | 0.020 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.555923e-01 | 0.020 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.555923e-01 | 0.020 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.555923e-01 | 0.020 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 9.555923e-01 | 0.020 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.555923e-01 | 0.020 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.555923e-01 | 0.020 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.580479e-01 | 0.019 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.580479e-01 | 0.019 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.596475e-01 | 0.018 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.614579e-01 | 0.017 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.614579e-01 | 0.017 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.614579e-01 | 0.017 | 0 | 0 |
| Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | R-HSA-2142670 | 9.614579e-01 | 0.017 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.614579e-01 | 0.017 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.614579e-01 | 0.017 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.614579e-01 | 0.017 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.616488e-01 | 0.017 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.616488e-01 | 0.017 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.616488e-01 | 0.017 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.616488e-01 | 0.017 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.616488e-01 | 0.017 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.616488e-01 | 0.017 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.627257e-01 | 0.016 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.627257e-01 | 0.016 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.633601e-01 | 0.016 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.654961e-01 | 0.015 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 9.665491e-01 | 0.015 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.665491e-01 | 0.015 | 0 | 0 |
| Amine Oxidase reactions | R-HSA-140179 | 9.665491e-01 | 0.015 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.665491e-01 | 0.015 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.665491e-01 | 0.015 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.665491e-01 | 0.015 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 9.668586e-01 | 0.015 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.669001e-01 | 0.015 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.669001e-01 | 0.015 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.669890e-01 | 0.015 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.689385e-01 | 0.014 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.689773e-01 | 0.014 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.689773e-01 | 0.014 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.695971e-01 | 0.013 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.709680e-01 | 0.013 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.709680e-01 | 0.013 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.709680e-01 | 0.013 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.709680e-01 | 0.013 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.709680e-01 | 0.013 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.721243e-01 | 0.012 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.721243e-01 | 0.012 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.726783e-01 | 0.012 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.739390e-01 | 0.011 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.745381e-01 | 0.011 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.748034e-01 | 0.011 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.748034e-01 | 0.011 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.748034e-01 | 0.011 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.748034e-01 | 0.011 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.748034e-01 | 0.011 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.749671e-01 | 0.011 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.754222e-01 | 0.011 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.765809e-01 | 0.010 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.768604e-01 | 0.010 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.768924e-01 | 0.010 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.768924e-01 | 0.010 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.768924e-01 | 0.010 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.770039e-01 | 0.010 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.781323e-01 | 0.010 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 9.781323e-01 | 0.010 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.781323e-01 | 0.010 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 9.781323e-01 | 0.010 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.781323e-01 | 0.010 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.781323e-01 | 0.010 | 0 | 0 |
| Glucocorticoid biosynthesis | R-HSA-194002 | 9.781323e-01 | 0.010 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.781323e-01 | 0.010 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.785524e-01 | 0.009 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.795205e-01 | 0.009 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.797385e-01 | 0.009 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.798469e-01 | 0.009 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.798469e-01 | 0.009 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.810215e-01 | 0.008 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.810215e-01 | 0.008 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.816813e-01 | 0.008 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.816926e-01 | 0.008 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.818577e-01 | 0.008 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.818577e-01 | 0.008 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.818577e-01 | 0.008 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.818577e-01 | 0.008 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.818944e-01 | 0.008 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.819031e-01 | 0.008 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.819324e-01 | 0.008 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.835292e-01 | 0.007 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.835292e-01 | 0.007 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.835292e-01 | 0.007 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.835292e-01 | 0.007 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.835292e-01 | 0.007 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.835292e-01 | 0.007 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.835292e-01 | 0.007 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.839350e-01 | 0.007 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.839350e-01 | 0.007 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.839350e-01 | 0.007 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.839350e-01 | 0.007 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.854097e-01 | 0.006 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.855008e-01 | 0.006 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.857056e-01 | 0.006 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.857056e-01 | 0.006 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 9.857056e-01 | 0.006 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.857056e-01 | 0.006 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.857056e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.857802e-01 | 0.006 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.857802e-01 | 0.006 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 9.860009e-01 | 0.006 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.874185e-01 | 0.005 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.875946e-01 | 0.005 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.875946e-01 | 0.005 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.875946e-01 | 0.005 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.875946e-01 | 0.005 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.875946e-01 | 0.005 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.878256e-01 | 0.005 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.883303e-01 | 0.005 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.888722e-01 | 0.005 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.888722e-01 | 0.005 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.892340e-01 | 0.005 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.892340e-01 | 0.005 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.896148e-01 | 0.005 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.896148e-01 | 0.005 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.901020e-01 | 0.004 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.906569e-01 | 0.004 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.906569e-01 | 0.004 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.906569e-01 | 0.004 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.906901e-01 | 0.004 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.910281e-01 | 0.004 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.910860e-01 | 0.004 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.913045e-01 | 0.004 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.913045e-01 | 0.004 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.913045e-01 | 0.004 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.918018e-01 | 0.004 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.918917e-01 | 0.004 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.918917e-01 | 0.004 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.923173e-01 | 0.003 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.926294e-01 | 0.003 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.927755e-01 | 0.003 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.929635e-01 | 0.003 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.929635e-01 | 0.003 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.933366e-01 | 0.003 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.933366e-01 | 0.003 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.935005e-01 | 0.003 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.937047e-01 | 0.003 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.938237e-01 | 0.003 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.938936e-01 | 0.003 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.939711e-01 | 0.003 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.940085e-01 | 0.003 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.940455e-01 | 0.003 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.941552e-01 | 0.003 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.947008e-01 | 0.002 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.947008e-01 | 0.002 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.947114e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.947114e-01 | 0.002 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.947114e-01 | 0.002 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.952794e-01 | 0.002 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.953332e-01 | 0.002 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.953332e-01 | 0.002 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.954014e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.957602e-01 | 0.002 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.958151e-01 | 0.002 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.959203e-01 | 0.002 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.959203e-01 | 0.002 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.959768e-01 | 0.002 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.960093e-01 | 0.002 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.962710e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.962710e-01 | 0.002 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.966669e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.966785e-01 | 0.001 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.969656e-01 | 0.001 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.969656e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.969656e-01 | 0.001 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.969949e-01 | 0.001 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.969949e-01 | 0.001 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.969949e-01 | 0.001 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.969949e-01 | 0.001 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.973922e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.974372e-01 | 0.001 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.975282e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.976408e-01 | 0.001 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.977371e-01 | 0.001 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.979608e-01 | 0.001 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.980128e-01 | 0.001 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.980363e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.980363e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.981603e-01 | 0.001 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.982419e-01 | 0.001 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.982960e-01 | 0.001 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.982960e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.983176e-01 | 0.001 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.985214e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.985214e-01 | 0.001 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.985214e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.985359e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.986140e-01 | 0.001 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.986830e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.986830e-01 | 0.001 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.988867e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.989660e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.989740e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.989740e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.989803e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.989803e-01 | 0.000 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.991618e-01 | 0.000 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.991618e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.991917e-01 | 0.000 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.992111e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.992111e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.992232e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.992727e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.992828e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.992828e-01 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.993305e-01 | 0.000 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.993689e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.993689e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.993901e-01 | 0.000 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.995249e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.995288e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.995567e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.995567e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.995860e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.995877e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.996896e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.996896e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.996896e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.996917e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.996943e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.997019e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.997194e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.997194e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.997194e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.997307e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.997307e-01 | 0.000 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.997664e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.997693e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.997907e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.998136e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998170e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.998537e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.998636e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.998716e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.998851e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999256e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999340e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.999349e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.999349e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999362e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999416e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999473e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999511e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999519e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999519e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999575e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999680e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999722e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.999864e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.999864e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999864e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999880e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999882e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999910e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.999923e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999943e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999959e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999959e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999960e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999967e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999968e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999977e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999979e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999979e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999984e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999985e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999986e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999993e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999993e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999993e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999994e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999994e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999996e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999997e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999998e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999998e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999998e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999998e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999998e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999999e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 2.220446e-16 | 15.654 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.521006e-14 | 13.818 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.592327e-14 | 13.018 | 0 | 0 |
| M Phase | R-HSA-68886 | 5.244694e-13 | 12.280 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.728262e-13 | 12.112 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.068701e-12 | 11.971 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.556755e-12 | 11.808 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.727441e-12 | 11.325 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.671630e-11 | 10.777 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.537759e-11 | 10.596 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.675937e-11 | 10.330 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.239398e-10 | 9.650 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.171521e-10 | 9.380 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.834877e-10 | 9.316 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.258233e-09 | 8.646 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.382308e-09 | 8.269 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 8.088803e-09 | 8.092 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.193192e-08 | 7.923 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.133831e-08 | 7.671 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.971740e-08 | 7.527 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.358220e-08 | 7.474 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.949473e-08 | 7.403 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.518359e-08 | 7.345 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.020711e-08 | 7.299 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.020711e-08 | 7.299 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.221296e-08 | 7.085 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 8.001881e-08 | 7.097 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.063661e-07 | 6.973 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.179173e-07 | 6.928 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.342444e-07 | 6.872 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.628950e-07 | 6.788 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.684773e-07 | 6.773 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.938354e-07 | 6.713 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.912694e-07 | 6.718 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.153702e-07 | 6.667 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.406130e-07 | 6.619 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.767301e-07 | 6.558 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.968209e-07 | 6.401 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.463062e-07 | 6.263 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.350091e-07 | 6.272 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.856146e-07 | 6.164 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.663545e-07 | 6.116 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.105395e-07 | 6.091 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.105395e-07 | 6.091 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.105395e-07 | 6.091 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.105395e-07 | 6.091 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 8.595079e-07 | 6.066 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.032444e-07 | 6.044 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.013988e-06 | 5.994 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.057133e-06 | 5.976 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.087566e-06 | 5.964 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.421912e-06 | 5.847 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.433534e-06 | 5.844 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.377543e-06 | 5.624 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.980873e-06 | 5.400 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.898264e-06 | 5.409 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.994470e-06 | 5.399 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 4.121024e-06 | 5.385 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.361737e-06 | 5.271 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 6.692991e-06 | 5.174 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 6.745092e-06 | 5.171 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.750420e-06 | 5.111 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.341073e-06 | 5.079 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 8.696978e-06 | 5.061 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.079455e-06 | 5.042 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.060421e-05 | 4.975 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.088722e-05 | 4.963 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.161507e-05 | 4.935 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.190982e-05 | 4.924 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.322275e-05 | 4.879 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.346363e-05 | 4.871 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.346363e-05 | 4.871 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.614111e-05 | 4.792 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.960037e-05 | 4.708 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.997056e-05 | 4.700 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.020920e-05 | 4.694 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.455371e-05 | 4.610 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.382596e-05 | 4.623 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.413390e-05 | 4.617 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.859399e-05 | 4.544 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.951341e-05 | 4.530 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.058061e-05 | 4.515 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.058061e-05 | 4.515 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.168957e-05 | 4.499 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.000256e-05 | 4.523 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.168957e-05 | 4.499 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.594865e-05 | 4.444 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.594865e-05 | 4.444 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.740538e-05 | 4.427 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.160124e-05 | 4.381 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.839445e-05 | 4.315 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 5.244086e-05 | 4.280 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.390269e-05 | 4.268 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.404915e-05 | 4.267 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 6.160169e-05 | 4.210 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.894344e-05 | 4.230 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.425130e-05 | 4.192 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.221965e-05 | 4.141 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.506627e-05 | 4.125 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.256807e-05 | 4.034 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.000477e-04 | 4.000 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.000477e-04 | 4.000 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.179456e-04 | 3.928 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.181970e-04 | 3.927 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.348009e-04 | 3.870 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.343341e-04 | 3.872 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.278208e-04 | 3.893 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.336649e-04 | 3.874 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.447521e-04 | 3.839 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.455654e-04 | 3.837 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.491233e-04 | 3.826 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.790275e-04 | 3.747 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.824920e-04 | 3.739 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.926639e-04 | 3.715 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.073100e-04 | 3.683 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.350529e-04 | 3.629 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.297569e-04 | 3.639 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.569974e-04 | 3.590 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.597652e-04 | 3.585 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.701090e-04 | 3.568 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.875871e-04 | 3.541 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.908601e-04 | 3.536 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.021139e-04 | 3.520 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.029802e-04 | 3.519 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.225859e-04 | 3.491 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.225859e-04 | 3.491 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.828337e-04 | 3.417 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.851999e-04 | 3.414 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.851999e-04 | 3.414 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 3.851999e-04 | 3.414 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.114183e-04 | 3.386 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.281629e-04 | 3.368 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.300046e-04 | 3.367 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.777625e-04 | 3.321 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.843611e-04 | 3.315 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.843611e-04 | 3.315 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.540254e-04 | 3.343 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.540254e-04 | 3.343 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.453645e-04 | 3.351 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.843611e-04 | 3.315 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.923655e-04 | 3.308 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.923655e-04 | 3.308 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.043640e-04 | 3.297 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.179540e-04 | 3.286 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.226693e-04 | 3.282 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.867567e-04 | 3.232 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.005905e-04 | 3.221 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.050195e-04 | 3.152 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 6.466055e-04 | 3.189 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 6.466055e-04 | 3.189 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.648792e-04 | 3.177 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.427650e-04 | 3.192 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 6.566831e-04 | 3.183 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 6.566831e-04 | 3.183 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.145399e-04 | 3.146 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.239519e-04 | 3.140 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 7.474816e-04 | 3.126 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.484013e-04 | 3.126 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 7.892958e-04 | 3.103 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.184179e-04 | 3.037 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 9.542370e-04 | 3.020 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 9.843075e-04 | 3.007 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.002695e-03 | 2.999 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.054661e-03 | 2.977 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.152234e-03 | 2.938 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.201223e-03 | 2.920 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.380646e-03 | 2.860 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.370744e-03 | 2.863 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.416913e-03 | 2.849 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.370744e-03 | 2.863 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.419202e-03 | 2.848 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.494653e-03 | 2.825 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.541907e-03 | 2.812 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.591778e-03 | 2.798 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.737866e-03 | 2.760 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.753406e-03 | 2.756 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.791872e-03 | 2.747 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.828092e-03 | 2.738 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.828092e-03 | 2.738 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.927162e-03 | 2.715 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.157302e-03 | 2.666 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.177020e-03 | 2.662 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.221730e-03 | 2.653 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.226561e-03 | 2.652 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.283794e-03 | 2.641 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.354626e-03 | 2.628 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.357269e-03 | 2.628 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.379621e-03 | 2.623 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.539745e-03 | 2.595 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.496997e-03 | 2.603 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.601954e-03 | 2.585 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.379621e-03 | 2.623 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.716619e-03 | 2.566 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.479734e-03 | 2.606 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.679198e-03 | 2.572 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.758870e-03 | 2.559 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.758870e-03 | 2.559 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.758870e-03 | 2.559 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.831289e-03 | 2.548 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.885159e-03 | 2.540 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.914135e-03 | 2.535 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.925507e-03 | 2.534 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.957750e-03 | 2.529 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.117890e-03 | 2.506 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.173441e-03 | 2.498 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.222252e-03 | 2.492 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.234594e-03 | 2.490 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 3.234594e-03 | 2.490 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.344763e-03 | 2.476 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.413896e-03 | 2.467 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.413896e-03 | 2.467 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.413896e-03 | 2.467 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.420474e-03 | 2.466 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.420474e-03 | 2.466 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.420474e-03 | 2.466 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.420474e-03 | 2.466 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.551871e-03 | 2.450 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.611322e-03 | 2.442 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.838086e-03 | 2.416 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.980622e-03 | 2.400 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.543501e-03 | 2.343 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 4.334202e-03 | 2.363 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.743145e-03 | 2.324 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.156585e-03 | 2.381 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 4.752239e-03 | 2.323 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.281059e-03 | 2.368 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.156585e-03 | 2.381 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.550844e-03 | 2.342 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.743145e-03 | 2.324 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.915575e-03 | 2.308 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.915575e-03 | 2.308 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.915575e-03 | 2.308 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.925724e-03 | 2.308 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.993116e-03 | 2.302 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.001509e-03 | 2.301 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.488438e-03 | 2.261 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.491886e-03 | 2.260 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.732091e-03 | 2.242 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.921469e-03 | 2.228 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 6.076167e-03 | 2.216 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 6.214336e-03 | 2.207 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 6.214336e-03 | 2.207 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 6.218190e-03 | 2.206 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.270843e-03 | 2.203 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.349294e-03 | 2.197 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.504361e-03 | 2.187 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.529576e-03 | 2.185 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.566888e-03 | 2.183 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.823259e-03 | 2.166 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.823550e-03 | 2.166 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 6.823550e-03 | 2.166 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.823550e-03 | 2.166 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 6.864822e-03 | 2.163 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.014014e-03 | 2.154 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.988062e-03 | 2.098 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 7.988062e-03 | 2.098 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.732507e-03 | 2.112 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.994779e-03 | 2.097 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.437164e-03 | 2.074 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 7.284703e-03 | 2.138 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.988062e-03 | 2.098 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.284703e-03 | 2.138 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 7.988062e-03 | 2.098 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.394546e-03 | 2.131 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.436406e-03 | 2.074 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 7.456969e-03 | 2.127 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.469810e-03 | 2.072 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.603134e-03 | 2.065 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.644227e-03 | 2.063 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.644227e-03 | 2.063 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 9.088023e-03 | 2.042 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.088023e-03 | 2.042 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.177870e-03 | 2.037 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 9.196886e-03 | 2.036 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.322353e-03 | 2.030 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.525897e-03 | 2.021 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.894002e-03 | 2.005 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.040617e-02 | 1.983 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.065123e-02 | 1.973 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.081925e-02 | 1.966 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.195447e-02 | 1.922 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.195447e-02 | 1.922 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.195447e-02 | 1.922 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.195447e-02 | 1.922 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.195447e-02 | 1.922 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.208500e-02 | 1.918 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.209994e-02 | 1.917 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.274310e-02 | 1.895 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.298419e-02 | 1.887 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.322947e-02 | 1.878 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.344327e-02 | 1.871 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.552696e-02 | 1.809 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.678672e-02 | 1.775 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.449789e-02 | 1.839 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.506932e-02 | 1.822 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.395702e-02 | 1.855 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.496399e-02 | 1.825 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.553331e-02 | 1.809 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.543610e-02 | 1.811 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.493712e-02 | 1.826 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.380480e-02 | 1.860 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.709810e-02 | 1.767 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 1.374332e-02 | 1.862 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.543610e-02 | 1.811 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.400452e-02 | 1.854 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.430784e-02 | 1.844 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.509897e-02 | 1.821 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.553331e-02 | 1.809 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.553331e-02 | 1.809 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.434219e-02 | 1.843 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.709810e-02 | 1.767 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.735070e-02 | 1.761 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.804329e-02 | 1.744 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.804329e-02 | 1.744 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 1.804329e-02 | 1.744 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.816576e-02 | 1.741 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.852317e-02 | 1.732 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.852317e-02 | 1.732 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.872989e-02 | 1.727 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.872989e-02 | 1.727 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.913792e-02 | 1.718 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.958247e-02 | 1.708 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.958247e-02 | 1.708 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.958247e-02 | 1.708 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.988807e-02 | 1.701 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.997395e-02 | 1.700 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.006081e-02 | 1.698 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 2.006081e-02 | 1.698 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.182816e-02 | 1.661 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.183308e-02 | 1.661 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.224666e-02 | 1.653 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.247367e-02 | 1.648 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.247367e-02 | 1.648 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.247367e-02 | 1.648 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.247367e-02 | 1.648 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.302495e-02 | 1.638 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.332449e-02 | 1.632 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.332449e-02 | 1.632 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 2.369292e-02 | 1.625 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.385536e-02 | 1.622 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.395911e-02 | 1.621 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.416103e-02 | 1.617 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 2.426781e-02 | 1.615 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.426781e-02 | 1.615 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 2.450360e-02 | 1.611 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.494350e-02 | 1.603 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.578714e-02 | 1.589 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.581831e-02 | 1.588 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.669054e-02 | 1.574 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.669054e-02 | 1.574 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.669054e-02 | 1.574 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.669054e-02 | 1.574 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.669054e-02 | 1.574 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.704314e-02 | 1.568 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.704314e-02 | 1.568 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.723028e-02 | 1.565 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.756643e-02 | 1.560 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.757676e-02 | 1.559 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.757676e-02 | 1.559 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.804880e-02 | 1.552 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.021540e-02 | 1.520 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.612573e-02 | 1.442 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.068027e-02 | 1.513 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.068027e-02 | 1.513 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.662209e-02 | 1.436 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.662209e-02 | 1.436 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.373747e-02 | 1.472 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.068027e-02 | 1.513 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.021540e-02 | 1.520 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.961890e-02 | 1.528 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.887254e-02 | 1.540 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.436715e-02 | 1.464 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.612573e-02 | 1.442 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.795342e-02 | 1.421 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.219652e-02 | 1.492 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.042519e-02 | 1.517 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.564538e-02 | 1.448 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.519057e-02 | 1.454 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.373747e-02 | 1.472 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.373747e-02 | 1.472 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.478889e-02 | 1.459 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.237838e-02 | 1.490 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.140087e-02 | 1.503 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.961890e-02 | 1.528 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.662209e-02 | 1.436 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.730070e-02 | 1.428 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.838444e-02 | 1.416 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.854190e-02 | 1.414 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 4.055510e-02 | 1.392 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 4.055510e-02 | 1.392 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.055510e-02 | 1.392 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.236851e-02 | 1.373 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.240637e-02 | 1.373 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.250853e-02 | 1.372 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.299981e-02 | 1.367 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.366652e-02 | 1.360 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.395982e-02 | 1.357 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.512086e-02 | 1.346 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.605794e-02 | 1.337 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.605794e-02 | 1.337 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.605794e-02 | 1.337 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.605794e-02 | 1.337 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.605794e-02 | 1.337 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.605794e-02 | 1.337 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.605794e-02 | 1.337 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.605794e-02 | 1.337 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 4.678597e-02 | 1.330 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.744968e-02 | 1.324 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.744968e-02 | 1.324 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.767480e-02 | 1.322 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.823159e-02 | 1.317 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.860292e-02 | 1.313 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.900102e-02 | 1.310 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.915035e-02 | 1.308 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.944941e-02 | 1.306 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 4.987139e-02 | 1.302 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.068739e-02 | 1.295 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.068739e-02 | 1.295 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.068739e-02 | 1.295 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.068739e-02 | 1.295 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.068739e-02 | 1.295 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.068739e-02 | 1.295 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.068739e-02 | 1.295 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.068739e-02 | 1.295 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.068739e-02 | 1.295 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.068739e-02 | 1.295 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.068739e-02 | 1.295 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.164343e-02 | 1.287 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.190365e-02 | 1.285 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.222929e-02 | 1.282 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.222929e-02 | 1.282 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.266783e-02 | 1.278 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.349013e-02 | 1.272 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.537449e-02 | 1.257 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.739962e-02 | 1.241 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.739962e-02 | 1.241 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.739962e-02 | 1.241 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.769612e-02 | 1.239 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.828471e-02 | 1.234 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.880238e-02 | 1.231 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.880238e-02 | 1.231 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.920127e-02 | 1.228 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.063010e-02 | 1.217 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.108030e-02 | 1.214 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.205941e-02 | 1.207 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.205941e-02 | 1.207 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.205941e-02 | 1.207 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.205941e-02 | 1.207 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.205941e-02 | 1.207 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 6.285395e-02 | 1.202 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.285395e-02 | 1.202 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 6.447007e-02 | 1.191 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 6.447007e-02 | 1.191 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.447007e-02 | 1.191 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.447007e-02 | 1.191 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.565865e-02 | 1.067 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 7.476783e-02 | 1.126 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 7.476783e-02 | 1.126 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.750639e-02 | 1.111 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.750639e-02 | 1.111 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.750639e-02 | 1.111 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.750639e-02 | 1.111 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.750639e-02 | 1.111 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 9.445068e-02 | 1.025 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 9.445068e-02 | 1.025 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 9.445068e-02 | 1.025 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 8.035035e-02 | 1.095 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 8.035035e-02 | 1.095 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.328745e-02 | 1.030 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 7.659666e-02 | 1.116 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.925409e-02 | 1.101 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.541723e-02 | 1.020 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.477820e-02 | 1.023 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 9.477820e-02 | 1.023 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 8.976559e-02 | 1.047 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.100247e-02 | 1.041 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.077985e-02 | 1.150 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.799819e-02 | 1.108 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.659666e-02 | 1.116 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.154518e-02 | 1.145 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 9.328745e-02 | 1.030 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.750639e-02 | 1.111 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.328745e-02 | 1.030 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 7.061475e-02 | 1.151 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 9.477820e-02 | 1.023 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.906276e-02 | 1.102 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.659666e-02 | 1.116 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 7.475711e-02 | 1.126 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.029614e-02 | 1.095 | 0 | 0 |
| Translation | R-HSA-72766 | 9.762764e-02 | 1.010 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 9.445068e-02 | 1.025 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 9.445068e-02 | 1.025 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.906276e-02 | 1.102 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 9.328745e-02 | 1.030 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.659666e-02 | 1.116 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 7.077985e-02 | 1.150 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.014464e-02 | 1.096 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.827039e-02 | 1.106 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 8.000231e-02 | 1.097 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.794687e-02 | 1.009 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 7.659666e-02 | 1.116 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.481195e-02 | 1.072 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.871625e-02 | 1.163 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 7.476783e-02 | 1.126 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 9.445068e-02 | 1.025 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.837554e-02 | 1.165 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.827176e-02 | 1.054 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.782500e-02 | 1.010 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.906276e-02 | 1.102 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 8.905710e-02 | 1.050 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 9.819342e-02 | 1.008 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 8.441987e-02 | 1.074 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.623422e-02 | 1.017 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.633139e-02 | 1.016 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 8.057024e-02 | 1.094 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.074120e-02 | 1.150 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 8.692777e-02 | 1.061 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.906276e-02 | 1.102 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 9.445068e-02 | 1.025 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 7.077985e-02 | 1.150 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 7.641703e-02 | 1.117 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.483261e-02 | 1.126 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 7.061475e-02 | 1.151 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 6.837554e-02 | 1.165 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.187549e-02 | 1.037 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.097768e-02 | 1.149 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.015565e-01 | 0.993 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.016892e-01 | 0.993 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.016892e-01 | 0.993 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.016892e-01 | 0.993 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.020827e-01 | 0.991 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.020827e-01 | 0.991 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.028859e-01 | 0.988 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.031728e-01 | 0.986 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.050348e-01 | 0.979 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.060127e-01 | 0.975 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 1.071420e-01 | 0.970 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.071420e-01 | 0.970 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.071420e-01 | 0.970 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.071420e-01 | 0.970 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.071420e-01 | 0.970 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.076276e-01 | 0.968 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.079031e-01 | 0.967 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.096329e-01 | 0.960 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.096329e-01 | 0.960 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.096991e-01 | 0.960 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.098929e-01 | 0.959 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.109216e-01 | 0.955 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 1.127575e-01 | 0.948 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 1.127575e-01 | 0.948 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.144115e-01 | 0.942 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.145988e-01 | 0.941 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.156490e-01 | 0.937 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.162425e-01 | 0.935 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.162425e-01 | 0.935 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.164220e-01 | 0.934 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.164220e-01 | 0.934 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.164220e-01 | 0.934 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.164220e-01 | 0.934 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.169369e-01 | 0.932 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.176239e-01 | 0.930 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.176749e-01 | 0.929 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.184929e-01 | 0.926 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.218623e-01 | 0.914 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.218623e-01 | 0.914 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 1.218623e-01 | 0.914 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.218623e-01 | 0.914 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.218623e-01 | 0.914 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.218623e-01 | 0.914 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.219609e-01 | 0.914 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.231670e-01 | 0.910 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.241051e-01 | 0.906 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.253141e-01 | 0.902 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.253141e-01 | 0.902 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.258528e-01 | 0.900 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.285613e-01 | 0.891 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.292805e-01 | 0.888 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.295784e-01 | 0.887 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.302949e-01 | 0.885 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.307888e-01 | 0.883 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.307888e-01 | 0.883 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.307888e-01 | 0.883 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 1.307888e-01 | 0.883 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.314794e-01 | 0.881 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.322840e-01 | 0.878 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.332411e-01 | 0.875 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.342638e-01 | 0.872 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.343803e-01 | 0.872 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.345498e-01 | 0.871 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.349020e-01 | 0.870 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.373910e-01 | 0.862 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.373910e-01 | 0.862 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.397159e-01 | 0.855 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.397159e-01 | 0.855 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.397159e-01 | 0.855 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.411417e-01 | 0.850 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.411417e-01 | 0.850 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.411417e-01 | 0.850 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.411417e-01 | 0.850 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.411417e-01 | 0.850 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.411417e-01 | 0.850 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.430795e-01 | 0.844 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.432004e-01 | 0.844 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.478374e-01 | 0.830 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.484244e-01 | 0.828 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.484244e-01 | 0.828 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.484244e-01 | 0.828 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.484244e-01 | 0.828 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.510481e-01 | 0.821 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.523489e-01 | 0.817 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.531626e-01 | 0.815 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.639846e-01 | 0.785 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.639846e-01 | 0.785 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.639846e-01 | 0.785 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.639846e-01 | 0.785 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.639846e-01 | 0.785 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.639846e-01 | 0.785 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.639846e-01 | 0.785 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.639846e-01 | 0.785 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.639846e-01 | 0.785 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.639846e-01 | 0.785 | 0 | 0 |
| TGFBR2 MSI Frameshift Mutants in Cancer | R-HSA-3642279 | 1.639846e-01 | 0.785 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 2.356050e-01 | 0.628 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.356050e-01 | 0.628 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.356050e-01 | 0.628 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.356050e-01 | 0.628 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.356050e-01 | 0.628 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.356050e-01 | 0.628 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.356050e-01 | 0.628 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.010937e-01 | 0.521 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.010937e-01 | 0.521 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.010937e-01 | 0.521 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.010937e-01 | 0.521 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.010937e-01 | 0.521 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.010937e-01 | 0.521 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.010937e-01 | 0.521 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.933239e-01 | 0.714 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 2.258542e-01 | 0.646 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.258542e-01 | 0.646 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 2.258542e-01 | 0.646 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.258542e-01 | 0.646 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.744085e-01 | 0.758 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.587337e-01 | 0.587 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.587337e-01 | 0.587 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.967139e-01 | 0.706 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.536664e-01 | 0.813 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.536664e-01 | 0.813 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.916641e-01 | 0.535 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.916641e-01 | 0.535 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.916641e-01 | 0.535 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.916641e-01 | 0.535 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 2.916641e-01 | 0.535 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.431057e-01 | 0.614 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.063118e-01 | 0.685 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.770722e-01 | 0.752 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.770722e-01 | 0.752 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 2.669274e-01 | 0.574 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.669274e-01 | 0.574 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.669274e-01 | 0.574 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.669274e-01 | 0.574 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.076029e-01 | 0.683 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 2.910022e-01 | 0.536 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.910022e-01 | 0.536 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.910022e-01 | 0.536 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.234733e-01 | 0.651 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.053612e-01 | 0.687 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.828596e-01 | 0.548 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.828596e-01 | 0.548 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.855475e-01 | 0.732 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.855475e-01 | 0.732 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.139209e-01 | 0.670 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.139209e-01 | 0.670 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.674701e-01 | 0.776 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.730032e-01 | 0.564 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.481029e-01 | 0.605 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.079766e-01 | 0.682 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.195720e-01 | 0.658 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.939400e-01 | 0.532 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.855475e-01 | 0.732 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 3.072020e-01 | 0.513 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.266934e-01 | 0.645 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.686060e-01 | 0.571 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.053612e-01 | 0.687 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.014226e-01 | 0.696 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.766304e-01 | 0.753 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.778875e-01 | 0.556 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.547521e-01 | 0.810 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.258542e-01 | 0.646 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.784882e-01 | 0.748 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.664497e-01 | 0.574 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.556985e-01 | 0.592 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.803499e-01 | 0.552 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.803499e-01 | 0.552 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.657669e-01 | 0.781 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.401794e-01 | 0.619 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.900125e-01 | 0.538 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.657669e-01 | 0.781 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 2.778875e-01 | 0.556 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.054449e-01 | 0.687 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.744085e-01 | 0.758 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 1.967139e-01 | 0.706 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.917442e-01 | 0.717 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.481029e-01 | 0.605 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.939400e-01 | 0.532 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.807387e-01 | 0.552 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.917442e-01 | 0.717 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.536664e-01 | 0.813 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.706234e-01 | 0.768 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.076029e-01 | 0.683 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.801106e-01 | 0.553 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 1.639846e-01 | 0.785 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 1.933239e-01 | 0.714 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 2.258542e-01 | 0.646 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.744085e-01 | 0.758 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.234733e-01 | 0.651 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.628855e-01 | 0.580 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 2.628855e-01 | 0.580 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.624934e-01 | 0.789 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.967139e-01 | 0.706 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.682603e-01 | 0.571 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.614966e-01 | 0.792 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.431057e-01 | 0.614 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.776592e-01 | 0.750 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.933239e-01 | 0.714 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.730032e-01 | 0.564 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.628855e-01 | 0.580 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 1.545554e-01 | 0.811 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.543627e-01 | 0.811 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 1.706234e-01 | 0.768 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 2.014226e-01 | 0.696 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 2.014226e-01 | 0.696 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.784882e-01 | 0.748 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.335688e-01 | 0.632 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.639846e-01 | 0.785 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.639846e-01 | 0.785 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.356050e-01 | 0.628 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.356050e-01 | 0.628 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.356050e-01 | 0.628 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.010937e-01 | 0.521 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.010937e-01 | 0.521 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 2.196582e-01 | 0.658 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 2.916641e-01 | 0.535 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.916641e-01 | 0.535 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.656193e-01 | 0.781 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.656193e-01 | 0.781 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.439062e-01 | 0.613 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.966302e-01 | 0.706 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.812538e-01 | 0.742 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.481029e-01 | 0.605 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.960830e-01 | 0.708 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.574568e-01 | 0.803 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.773781e-01 | 0.557 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.638725e-01 | 0.579 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.388890e-01 | 0.622 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.061891e-01 | 0.514 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.860184e-01 | 0.730 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.063884e-01 | 0.514 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.933239e-01 | 0.714 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.916641e-01 | 0.535 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.900125e-01 | 0.538 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.072020e-01 | 0.513 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.072020e-01 | 0.513 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 1.755184e-01 | 0.756 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 2.529789e-01 | 0.597 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 1.656193e-01 | 0.781 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.914161e-01 | 0.718 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.646404e-01 | 0.783 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 1.770722e-01 | 0.752 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.784882e-01 | 0.748 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.139209e-01 | 0.670 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.773270e-01 | 0.751 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.035879e-01 | 0.691 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.356050e-01 | 0.628 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.614966e-01 | 0.792 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.669274e-01 | 0.574 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.773270e-01 | 0.751 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.481029e-01 | 0.605 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.868205e-01 | 0.729 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.711691e-01 | 0.767 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.014226e-01 | 0.696 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.766304e-01 | 0.753 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.531705e-01 | 0.597 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.906390e-01 | 0.720 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.674701e-01 | 0.776 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.054449e-01 | 0.687 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.759011e-01 | 0.559 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 2.196582e-01 | 0.658 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.455913e-01 | 0.610 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.792845e-01 | 0.554 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.747423e-01 | 0.758 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.922338e-01 | 0.534 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.587337e-01 | 0.587 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 2.587337e-01 | 0.587 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 2.434488e-01 | 0.614 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 1.770722e-01 | 0.752 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.934958e-01 | 0.532 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 2.939400e-01 | 0.532 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.258542e-01 | 0.646 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.916641e-01 | 0.535 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.431057e-01 | 0.614 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.934958e-01 | 0.532 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.949916e-01 | 0.710 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.536664e-01 | 0.813 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.063118e-01 | 0.685 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.825535e-01 | 0.739 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.910022e-01 | 0.536 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.234733e-01 | 0.651 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 2.196582e-01 | 0.658 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.431057e-01 | 0.614 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.084329e-01 | 0.511 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 3.096191e-01 | 0.509 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.152168e-01 | 0.501 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.152168e-01 | 0.501 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.152168e-01 | 0.501 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 3.152168e-01 | 0.501 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 3.152168e-01 | 0.501 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.164761e-01 | 0.500 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.226473e-01 | 0.491 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 3.226473e-01 | 0.491 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.226473e-01 | 0.491 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.229732e-01 | 0.491 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.239185e-01 | 0.490 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.239185e-01 | 0.490 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.239185e-01 | 0.490 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.243957e-01 | 0.489 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.243957e-01 | 0.489 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.243957e-01 | 0.489 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.243957e-01 | 0.489 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.243957e-01 | 0.489 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.243957e-01 | 0.489 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.245315e-01 | 0.489 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.245315e-01 | 0.489 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.245666e-01 | 0.489 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 3.285879e-01 | 0.483 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.305925e-01 | 0.481 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.353791e-01 | 0.474 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.361267e-01 | 0.473 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.372869e-01 | 0.472 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.394667e-01 | 0.469 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.394667e-01 | 0.469 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.394667e-01 | 0.469 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.394667e-01 | 0.469 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.395082e-01 | 0.469 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.395082e-01 | 0.469 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 3.395082e-01 | 0.469 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.395082e-01 | 0.469 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.413510e-01 | 0.467 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.419613e-01 | 0.466 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.426997e-01 | 0.465 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.426997e-01 | 0.465 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.481441e-01 | 0.458 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.505094e-01 | 0.455 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.505094e-01 | 0.455 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.505094e-01 | 0.455 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.567209e-01 | 0.448 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.567209e-01 | 0.448 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.567209e-01 | 0.448 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.567209e-01 | 0.448 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.567209e-01 | 0.448 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.567209e-01 | 0.448 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 3.567209e-01 | 0.448 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 3.567209e-01 | 0.448 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.570609e-01 | 0.447 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.589744e-01 | 0.445 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.594531e-01 | 0.444 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.594531e-01 | 0.444 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.609753e-01 | 0.443 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.609753e-01 | 0.443 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 3.609753e-01 | 0.443 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.609753e-01 | 0.443 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.609753e-01 | 0.443 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.625374e-01 | 0.441 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.627810e-01 | 0.440 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.636559e-01 | 0.439 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.636559e-01 | 0.439 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.636559e-01 | 0.439 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 3.636559e-01 | 0.439 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 3.636559e-01 | 0.439 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.643121e-01 | 0.439 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 3.657079e-01 | 0.437 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.708888e-01 | 0.431 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.769701e-01 | 0.424 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.774321e-01 | 0.423 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.781879e-01 | 0.422 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.796224e-01 | 0.421 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.828374e-01 | 0.417 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.828374e-01 | 0.417 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.828374e-01 | 0.417 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.876972e-01 | 0.412 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 3.876972e-01 | 0.412 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.876972e-01 | 0.412 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.876972e-01 | 0.412 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.884693e-01 | 0.411 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.884693e-01 | 0.411 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.884693e-01 | 0.411 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.884693e-01 | 0.411 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.884693e-01 | 0.411 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.884693e-01 | 0.411 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.906989e-01 | 0.408 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 3.936570e-01 | 0.405 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.944767e-01 | 0.404 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.944767e-01 | 0.404 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 3.944767e-01 | 0.404 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.944767e-01 | 0.404 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.964866e-01 | 0.402 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.977467e-01 | 0.400 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.981784e-01 | 0.400 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.990134e-01 | 0.399 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 4.020910e-01 | 0.396 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.023604e-01 | 0.395 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.023604e-01 | 0.395 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.023604e-01 | 0.395 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.028183e-01 | 0.395 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.028183e-01 | 0.395 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 4.080679e-01 | 0.389 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.115116e-01 | 0.386 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.119391e-01 | 0.385 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.119391e-01 | 0.385 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.130728e-01 | 0.384 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.157296e-01 | 0.381 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.157296e-01 | 0.381 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.157296e-01 | 0.381 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.157296e-01 | 0.381 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.157296e-01 | 0.381 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.157296e-01 | 0.381 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.157296e-01 | 0.381 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.157296e-01 | 0.381 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.157296e-01 | 0.381 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 4.157296e-01 | 0.381 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.157296e-01 | 0.381 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.157296e-01 | 0.381 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.195026e-01 | 0.377 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.195026e-01 | 0.377 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.195026e-01 | 0.377 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.195026e-01 | 0.377 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.195026e-01 | 0.377 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.195026e-01 | 0.377 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.195026e-01 | 0.377 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.195026e-01 | 0.377 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.195026e-01 | 0.377 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.195026e-01 | 0.377 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.195026e-01 | 0.377 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.195026e-01 | 0.377 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.195026e-01 | 0.377 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.224607e-01 | 0.374 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.226766e-01 | 0.374 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.257502e-01 | 0.371 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.293250e-01 | 0.367 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.293250e-01 | 0.367 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.293250e-01 | 0.367 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.318587e-01 | 0.365 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.337217e-01 | 0.363 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.350288e-01 | 0.361 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 4.350288e-01 | 0.361 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.350288e-01 | 0.361 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.368170e-01 | 0.360 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.423686e-01 | 0.354 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.466041e-01 | 0.350 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.466041e-01 | 0.350 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.497103e-01 | 0.347 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.497103e-01 | 0.347 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.497103e-01 | 0.347 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 4.497103e-01 | 0.347 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.497103e-01 | 0.347 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.497103e-01 | 0.347 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 4.581862e-01 | 0.339 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 4.581862e-01 | 0.339 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.581862e-01 | 0.339 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.618538e-01 | 0.335 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.618538e-01 | 0.335 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.647871e-01 | 0.333 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 4.657017e-01 | 0.332 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.657952e-01 | 0.332 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.657952e-01 | 0.332 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 4.657952e-01 | 0.332 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.657952e-01 | 0.332 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.657952e-01 | 0.332 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 4.657952e-01 | 0.332 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 4.657952e-01 | 0.332 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.657952e-01 | 0.332 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.657952e-01 | 0.332 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.657952e-01 | 0.332 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.657952e-01 | 0.332 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.657952e-01 | 0.332 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.657952e-01 | 0.332 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 4.657952e-01 | 0.332 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 4.657952e-01 | 0.332 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.732719e-01 | 0.325 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.759547e-01 | 0.322 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.780786e-01 | 0.321 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.790061e-01 | 0.320 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.790061e-01 | 0.320 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.790061e-01 | 0.320 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.809289e-01 | 0.318 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.809289e-01 | 0.318 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.809289e-01 | 0.318 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.810954e-01 | 0.318 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.810954e-01 | 0.318 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.854521e-01 | 0.314 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 4.877527e-01 | 0.312 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.890211e-01 | 0.311 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.975233e-01 | 0.303 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.975233e-01 | 0.303 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.975233e-01 | 0.303 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.000598e-01 | 0.301 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.000598e-01 | 0.301 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.000598e-01 | 0.301 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.032092e-01 | 0.298 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.032092e-01 | 0.298 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.039061e-01 | 0.298 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.039061e-01 | 0.298 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.073245e-01 | 0.295 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.073245e-01 | 0.295 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.073245e-01 | 0.295 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 5.073245e-01 | 0.295 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.081041e-01 | 0.294 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.097826e-01 | 0.293 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.115735e-01 | 0.291 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.115735e-01 | 0.291 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.115735e-01 | 0.291 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.115735e-01 | 0.291 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.115735e-01 | 0.291 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.115735e-01 | 0.291 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.115735e-01 | 0.291 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.115735e-01 | 0.291 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 5.115735e-01 | 0.291 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 5.115735e-01 | 0.291 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.115735e-01 | 0.291 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.115735e-01 | 0.291 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.115735e-01 | 0.291 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 5.115735e-01 | 0.291 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.115735e-01 | 0.291 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.115735e-01 | 0.291 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.115735e-01 | 0.291 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.115735e-01 | 0.291 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.115735e-01 | 0.291 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.115735e-01 | 0.291 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.115735e-01 | 0.291 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.121386e-01 | 0.291 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.121386e-01 | 0.291 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.121386e-01 | 0.291 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.141073e-01 | 0.289 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 5.141073e-01 | 0.289 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.187167e-01 | 0.285 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.206995e-01 | 0.283 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.235816e-01 | 0.281 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.249863e-01 | 0.280 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 5.255213e-01 | 0.279 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.268291e-01 | 0.278 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.346180e-01 | 0.272 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.346180e-01 | 0.272 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.370390e-01 | 0.270 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.370390e-01 | 0.270 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.415844e-01 | 0.266 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.462256e-01 | 0.263 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 5.462256e-01 | 0.263 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 5.462256e-01 | 0.263 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.534313e-01 | 0.257 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 5.534313e-01 | 0.257 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.534313e-01 | 0.257 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.534313e-01 | 0.257 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.534313e-01 | 0.257 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.534313e-01 | 0.257 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.534313e-01 | 0.257 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.534313e-01 | 0.257 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.550027e-01 | 0.256 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.599841e-01 | 0.252 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 5.608542e-01 | 0.251 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.616945e-01 | 0.250 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.616945e-01 | 0.250 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.623947e-01 | 0.250 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.635501e-01 | 0.249 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.667263e-01 | 0.247 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.668987e-01 | 0.246 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.668987e-01 | 0.246 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.668987e-01 | 0.246 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.693076e-01 | 0.245 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.860139e-01 | 0.232 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.860139e-01 | 0.232 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.860139e-01 | 0.232 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.860139e-01 | 0.232 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.860139e-01 | 0.232 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.869823e-01 | 0.231 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.869823e-01 | 0.231 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.869823e-01 | 0.231 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.869823e-01 | 0.231 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.877808e-01 | 0.231 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.897734e-01 | 0.229 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.917042e-01 | 0.228 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.917042e-01 | 0.228 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 5.917042e-01 | 0.228 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.917042e-01 | 0.228 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.917042e-01 | 0.228 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.917042e-01 | 0.228 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 5.917042e-01 | 0.228 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.917042e-01 | 0.228 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 5.917042e-01 | 0.228 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.917042e-01 | 0.228 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 5.917042e-01 | 0.228 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.917042e-01 | 0.228 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 5.917042e-01 | 0.228 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 5.917042e-01 | 0.228 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.005300e-01 | 0.221 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 6.047966e-01 | 0.218 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.064584e-01 | 0.217 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.065469e-01 | 0.217 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.065469e-01 | 0.217 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.070087e-01 | 0.217 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 6.081342e-01 | 0.216 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 6.094875e-01 | 0.215 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.100889e-01 | 0.215 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.100889e-01 | 0.215 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.100889e-01 | 0.215 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.100889e-01 | 0.215 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.108012e-01 | 0.214 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.123648e-01 | 0.213 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.227524e-01 | 0.206 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.227524e-01 | 0.206 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.228943e-01 | 0.206 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.228943e-01 | 0.206 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.253135e-01 | 0.204 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 6.253135e-01 | 0.204 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.253989e-01 | 0.204 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.253989e-01 | 0.204 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 6.266991e-01 | 0.203 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.266991e-01 | 0.203 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.266991e-01 | 0.203 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.266991e-01 | 0.203 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.266991e-01 | 0.203 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.266991e-01 | 0.203 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.266991e-01 | 0.203 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.266991e-01 | 0.203 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.266991e-01 | 0.203 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.266991e-01 | 0.203 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.330804e-01 | 0.199 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.368245e-01 | 0.196 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.388053e-01 | 0.195 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 6.388053e-01 | 0.195 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.394888e-01 | 0.194 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.441034e-01 | 0.191 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.441034e-01 | 0.191 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.441034e-01 | 0.191 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.493816e-01 | 0.188 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.498611e-01 | 0.187 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.542717e-01 | 0.184 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.542717e-01 | 0.184 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.542717e-01 | 0.184 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.549971e-01 | 0.184 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.549971e-01 | 0.184 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.549971e-01 | 0.184 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.570366e-01 | 0.182 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 6.586964e-01 | 0.181 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.586964e-01 | 0.181 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.586964e-01 | 0.181 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.586964e-01 | 0.181 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.586964e-01 | 0.181 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.586964e-01 | 0.181 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.586964e-01 | 0.181 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.586964e-01 | 0.181 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 6.586964e-01 | 0.181 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.586964e-01 | 0.181 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.586964e-01 | 0.181 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.586964e-01 | 0.181 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.611277e-01 | 0.180 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.611277e-01 | 0.180 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.611360e-01 | 0.180 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.629454e-01 | 0.179 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 6.638319e-01 | 0.178 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.642108e-01 | 0.178 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.721516e-01 | 0.173 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.721516e-01 | 0.173 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.743655e-01 | 0.171 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.743655e-01 | 0.171 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 6.758544e-01 | 0.170 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.758544e-01 | 0.170 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.758544e-01 | 0.170 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.758544e-01 | 0.170 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.758544e-01 | 0.170 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 6.778443e-01 | 0.169 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.780792e-01 | 0.169 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.780792e-01 | 0.169 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.810162e-01 | 0.167 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 6.838485e-01 | 0.165 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 6.863095e-01 | 0.163 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 6.870870e-01 | 0.163 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 6.879529e-01 | 0.162 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.879529e-01 | 0.162 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.879529e-01 | 0.162 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.879529e-01 | 0.162 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.879529e-01 | 0.162 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.879529e-01 | 0.162 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 6.879529e-01 | 0.162 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.879529e-01 | 0.162 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.879529e-01 | 0.162 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.879529e-01 | 0.162 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 6.879529e-01 | 0.162 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 6.879529e-01 | 0.162 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 6.907430e-01 | 0.161 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.943940e-01 | 0.158 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 6.943940e-01 | 0.158 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.979524e-01 | 0.156 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.979524e-01 | 0.156 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.144773e-01 | 0.146 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 7.144773e-01 | 0.146 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.144773e-01 | 0.146 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.144773e-01 | 0.146 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.147031e-01 | 0.146 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.147031e-01 | 0.146 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.147031e-01 | 0.146 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.147031e-01 | 0.146 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 7.147031e-01 | 0.146 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.147031e-01 | 0.146 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 7.147031e-01 | 0.146 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.147031e-01 | 0.146 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.147031e-01 | 0.146 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.147031e-01 | 0.146 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.147031e-01 | 0.146 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.147031e-01 | 0.146 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 7.311550e-01 | 0.136 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.322958e-01 | 0.135 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.322958e-01 | 0.135 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.322958e-01 | 0.135 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.322958e-01 | 0.135 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.343442e-01 | 0.134 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.358390e-01 | 0.133 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 7.375237e-01 | 0.132 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.375237e-01 | 0.132 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.391615e-01 | 0.131 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.391615e-01 | 0.131 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.391615e-01 | 0.131 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.391615e-01 | 0.131 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.391615e-01 | 0.131 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.391615e-01 | 0.131 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.391615e-01 | 0.131 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.391615e-01 | 0.131 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.391615e-01 | 0.131 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.391615e-01 | 0.131 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.391615e-01 | 0.131 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.391615e-01 | 0.131 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 7.395664e-01 | 0.131 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.426254e-01 | 0.129 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.453680e-01 | 0.128 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.491592e-01 | 0.125 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.491592e-01 | 0.125 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.491592e-01 | 0.125 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 7.491592e-01 | 0.125 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.491592e-01 | 0.125 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.495863e-01 | 0.125 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 7.518036e-01 | 0.124 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 7.533937e-01 | 0.123 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.583603e-01 | 0.120 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.615245e-01 | 0.118 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 7.615245e-01 | 0.118 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.615245e-01 | 0.118 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.615245e-01 | 0.118 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.615245e-01 | 0.118 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 7.615245e-01 | 0.118 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.615245e-01 | 0.118 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.615245e-01 | 0.118 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.615245e-01 | 0.118 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.615245e-01 | 0.118 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.615245e-01 | 0.118 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.615245e-01 | 0.118 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.615245e-01 | 0.118 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 7.615245e-01 | 0.118 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 7.615245e-01 | 0.118 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 7.615245e-01 | 0.118 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.615245e-01 | 0.118 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.616468e-01 | 0.118 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.616468e-01 | 0.118 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.651003e-01 | 0.116 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.651003e-01 | 0.116 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.651003e-01 | 0.116 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.651003e-01 | 0.116 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.651003e-01 | 0.116 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.651003e-01 | 0.116 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.651003e-01 | 0.116 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.651003e-01 | 0.116 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.651003e-01 | 0.116 | 0 | 0 |
| Depurination | R-HSA-73927 | 7.666238e-01 | 0.115 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 7.712737e-01 | 0.113 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.792698e-01 | 0.108 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.799914e-01 | 0.108 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.801532e-01 | 0.108 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.801532e-01 | 0.108 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.801532e-01 | 0.108 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.805711e-01 | 0.108 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.815139e-01 | 0.107 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 7.819714e-01 | 0.107 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.819714e-01 | 0.107 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 7.819714e-01 | 0.107 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.819714e-01 | 0.107 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.819714e-01 | 0.107 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 7.819714e-01 | 0.107 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 7.819714e-01 | 0.107 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.899264e-01 | 0.102 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.943530e-01 | 0.100 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.943530e-01 | 0.100 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.943530e-01 | 0.100 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.943530e-01 | 0.100 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.943530e-01 | 0.100 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 7.980930e-01 | 0.098 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.006663e-01 | 0.097 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.006663e-01 | 0.097 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.006663e-01 | 0.097 | 0 | 0 |
| Transport of fatty acids | R-HSA-804914 | 8.006663e-01 | 0.097 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.006663e-01 | 0.097 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.006663e-01 | 0.097 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.006663e-01 | 0.097 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.006663e-01 | 0.097 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 8.006663e-01 | 0.097 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.006663e-01 | 0.097 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.006663e-01 | 0.097 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.025385e-01 | 0.096 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.025385e-01 | 0.096 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.025385e-01 | 0.096 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.046697e-01 | 0.094 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.060161e-01 | 0.094 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.067456e-01 | 0.093 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.077353e-01 | 0.093 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.077353e-01 | 0.093 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.077353e-01 | 0.093 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.077353e-01 | 0.093 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.077353e-01 | 0.093 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.136643e-01 | 0.090 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.136643e-01 | 0.090 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.138474e-01 | 0.089 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 8.138474e-01 | 0.089 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.177592e-01 | 0.087 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.177592e-01 | 0.087 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.177592e-01 | 0.087 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.177592e-01 | 0.087 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.177592e-01 | 0.087 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.177592e-01 | 0.087 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.177592e-01 | 0.087 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.177592e-01 | 0.087 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.177592e-01 | 0.087 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.177592e-01 | 0.087 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.203359e-01 | 0.086 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 8.203359e-01 | 0.086 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.243055e-01 | 0.084 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 8.262808e-01 | 0.083 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 8.280453e-01 | 0.082 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.321903e-01 | 0.080 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.321903e-01 | 0.080 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.321903e-01 | 0.080 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.321903e-01 | 0.080 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.326161e-01 | 0.080 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.333874e-01 | 0.079 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.333874e-01 | 0.079 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.333874e-01 | 0.079 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.333874e-01 | 0.079 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.333874e-01 | 0.079 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.333874e-01 | 0.079 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.333874e-01 | 0.079 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.333874e-01 | 0.079 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.333874e-01 | 0.079 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.333874e-01 | 0.079 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.333874e-01 | 0.079 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.342571e-01 | 0.079 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.398840e-01 | 0.076 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.406125e-01 | 0.075 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.433339e-01 | 0.074 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 8.476761e-01 | 0.072 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.476761e-01 | 0.072 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.476761e-01 | 0.072 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.476761e-01 | 0.072 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 8.476761e-01 | 0.072 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.476761e-01 | 0.072 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.476761e-01 | 0.072 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 8.538013e-01 | 0.069 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.538013e-01 | 0.069 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.538013e-01 | 0.069 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.607403e-01 | 0.065 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.607403e-01 | 0.065 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.607403e-01 | 0.065 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 8.636265e-01 | 0.064 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.636265e-01 | 0.064 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.646121e-01 | 0.063 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.726847e-01 | 0.059 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.726847e-01 | 0.059 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.726847e-01 | 0.059 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.726847e-01 | 0.059 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.726847e-01 | 0.059 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.726847e-01 | 0.059 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.726847e-01 | 0.059 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.726847e-01 | 0.059 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.726847e-01 | 0.059 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.728426e-01 | 0.059 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.728426e-01 | 0.059 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.728426e-01 | 0.059 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.802567e-01 | 0.055 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.810651e-01 | 0.055 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.814819e-01 | 0.055 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.814819e-01 | 0.055 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.814819e-01 | 0.055 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.836053e-01 | 0.054 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.836053e-01 | 0.054 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.836053e-01 | 0.054 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.836053e-01 | 0.054 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 8.836053e-01 | 0.054 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 8.836053e-01 | 0.054 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.836053e-01 | 0.054 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 8.836053e-01 | 0.054 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 8.836053e-01 | 0.054 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.836053e-01 | 0.054 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.850319e-01 | 0.053 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.850319e-01 | 0.053 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.895754e-01 | 0.051 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.895754e-01 | 0.051 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.912154e-01 | 0.050 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.929548e-01 | 0.049 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.935897e-01 | 0.049 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.935897e-01 | 0.049 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.935897e-01 | 0.049 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.935897e-01 | 0.049 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.935897e-01 | 0.049 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.935897e-01 | 0.049 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.945160e-01 | 0.048 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.945160e-01 | 0.048 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.945160e-01 | 0.048 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.971531e-01 | 0.047 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.971531e-01 | 0.047 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.971531e-01 | 0.047 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.000242e-01 | 0.046 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.023800e-01 | 0.045 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.027182e-01 | 0.044 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.027182e-01 | 0.044 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.027182e-01 | 0.044 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.027182e-01 | 0.044 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.027182e-01 | 0.044 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.027182e-01 | 0.044 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.042441e-01 | 0.044 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.042441e-01 | 0.044 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.092050e-01 | 0.041 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.096906e-01 | 0.041 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.108759e-01 | 0.041 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.108759e-01 | 0.041 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 9.110641e-01 | 0.040 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.110641e-01 | 0.040 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.110641e-01 | 0.040 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.110641e-01 | 0.040 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 9.110641e-01 | 0.040 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.110641e-01 | 0.040 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.110641e-01 | 0.040 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.118633e-01 | 0.040 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.136005e-01 | 0.039 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.152129e-01 | 0.038 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.170751e-01 | 0.038 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.185080e-01 | 0.037 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.186945e-01 | 0.037 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.203915e-01 | 0.036 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.228672e-01 | 0.035 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.228672e-01 | 0.035 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.228672e-01 | 0.035 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.228672e-01 | 0.035 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.228672e-01 | 0.035 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.228672e-01 | 0.035 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.256706e-01 | 0.034 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.256706e-01 | 0.034 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.256706e-01 | 0.034 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.256706e-01 | 0.034 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.256706e-01 | 0.034 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.256706e-01 | 0.034 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.256706e-01 | 0.034 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.256706e-01 | 0.034 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.256706e-01 | 0.034 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.258598e-01 | 0.033 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.282763e-01 | 0.032 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.320485e-01 | 0.031 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.320485e-01 | 0.031 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.320485e-01 | 0.031 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.320485e-01 | 0.031 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.333255e-01 | 0.030 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.333255e-01 | 0.030 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.333255e-01 | 0.030 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.333255e-01 | 0.030 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.342822e-01 | 0.030 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.346718e-01 | 0.029 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.378795e-01 | 0.028 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.378795e-01 | 0.028 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.378795e-01 | 0.028 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.378795e-01 | 0.028 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.378795e-01 | 0.028 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.380368e-01 | 0.028 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.380368e-01 | 0.028 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.380368e-01 | 0.028 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.380368e-01 | 0.028 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.383915e-01 | 0.028 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.383915e-01 | 0.028 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.383915e-01 | 0.028 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.402755e-01 | 0.027 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.408621e-01 | 0.026 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.412448e-01 | 0.026 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.421001e-01 | 0.026 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.422619e-01 | 0.026 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.424308e-01 | 0.026 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.432105e-01 | 0.025 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.432105e-01 | 0.025 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.432105e-01 | 0.025 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.432105e-01 | 0.025 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.459057e-01 | 0.024 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.465274e-01 | 0.024 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.465274e-01 | 0.024 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.480843e-01 | 0.023 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.480843e-01 | 0.023 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.480843e-01 | 0.023 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.486538e-01 | 0.023 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.486538e-01 | 0.023 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.493347e-01 | 0.023 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.498997e-01 | 0.022 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.503452e-01 | 0.022 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.503452e-01 | 0.022 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.503452e-01 | 0.022 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.525400e-01 | 0.021 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.525400e-01 | 0.021 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.525400e-01 | 0.021 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.539018e-01 | 0.020 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.539018e-01 | 0.020 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.566136e-01 | 0.019 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.566136e-01 | 0.019 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.572703e-01 | 0.019 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.602976e-01 | 0.018 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.603378e-01 | 0.018 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.603378e-01 | 0.018 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.603378e-01 | 0.018 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.611220e-01 | 0.017 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.620687e-01 | 0.017 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.629776e-01 | 0.016 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.636374e-01 | 0.016 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.637425e-01 | 0.016 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.637425e-01 | 0.016 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.637425e-01 | 0.016 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.658370e-01 | 0.015 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.663081e-01 | 0.015 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.668551e-01 | 0.015 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.673411e-01 | 0.014 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.702945e-01 | 0.013 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.717063e-01 | 0.012 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.722445e-01 | 0.012 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.727748e-01 | 0.012 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.743148e-01 | 0.011 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.746803e-01 | 0.011 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.746803e-01 | 0.011 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.746803e-01 | 0.011 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.766216e-01 | 0.010 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.768544e-01 | 0.010 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.768544e-01 | 0.010 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.768544e-01 | 0.010 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.788420e-01 | 0.009 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.788420e-01 | 0.009 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.806590e-01 | 0.008 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.806590e-01 | 0.008 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.806590e-01 | 0.008 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.811395e-01 | 0.008 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.821424e-01 | 0.008 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.823201e-01 | 0.008 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.823201e-01 | 0.008 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.823201e-01 | 0.008 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.823201e-01 | 0.008 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.832547e-01 | 0.007 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.832547e-01 | 0.007 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.832547e-01 | 0.007 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.838386e-01 | 0.007 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.838386e-01 | 0.007 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.840767e-01 | 0.007 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.844005e-01 | 0.007 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.844005e-01 | 0.007 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.852267e-01 | 0.006 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.852267e-01 | 0.006 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.852267e-01 | 0.006 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.852267e-01 | 0.006 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.852614e-01 | 0.006 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.852614e-01 | 0.006 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.862106e-01 | 0.006 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.863603e-01 | 0.006 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.863603e-01 | 0.006 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.864957e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.876558e-01 | 0.005 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.876558e-01 | 0.005 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.886660e-01 | 0.005 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.887163e-01 | 0.005 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.887174e-01 | 0.005 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.894100e-01 | 0.005 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.896857e-01 | 0.005 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.896857e-01 | 0.005 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.905719e-01 | 0.004 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.905719e-01 | 0.004 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.907622e-01 | 0.004 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.909087e-01 | 0.004 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.911308e-01 | 0.004 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.913820e-01 | 0.004 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.914585e-01 | 0.004 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.921225e-01 | 0.003 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.923747e-01 | 0.003 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.927995e-01 | 0.003 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.931747e-01 | 0.003 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.932536e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.934183e-01 | 0.003 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.937654e-01 | 0.003 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.938578e-01 | 0.003 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.939839e-01 | 0.003 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.939839e-01 | 0.003 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.945010e-01 | 0.002 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.949150e-01 | 0.002 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.949737e-01 | 0.002 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.955618e-01 | 0.002 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.968502e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.970691e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.972569e-01 | 0.001 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.975515e-01 | 0.001 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.975515e-01 | 0.001 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.976032e-01 | 0.001 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.976071e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.977620e-01 | 0.001 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.977620e-01 | 0.001 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.978462e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.982913e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.988076e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.989102e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.990897e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.991681e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.991681e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.992052e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.992888e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.993051e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.993649e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.993776e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.993960e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.994196e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.995569e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.995569e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.995895e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.995951e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.995991e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.996618e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.997055e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.997747e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.998063e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.998112e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.998507e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.998507e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999043e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999096e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999200e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999411e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999597e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999626e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999673e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999696e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999842e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999868e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999896e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999943e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999955e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999960e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999976e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999982e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999987e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999988e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999990e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999990e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999993e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999995e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999998e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999999e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |